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Summary
Objective: Magnetic resonance imaging (MRI) is a three-dimensional imaging technique with unparalleled ability to evaluate articular cartilage.
This report reviews the current status of morphological assessment of cartilage with quantitative MRI (qMRI), and its relevance for identifying
disease status, and monitoring progression and treatment response in knee osteoarthritis (OA).
Method: An international panel of experts in MRI of knee OA, with direct experience in the analysis of cartilage morphology with qMRI, re-
viewed the existing published and unpublished data on the subject, and debated the ﬁndings at the OMERACTeOARSI Workshop on Imaging
technologies (December 2002, Bethesda, MA) with scientists and clinicians from academia, the pharmaceutical industry and the regulatory
agencies. This report reviews (1) MRI pulse sequence considerations for morphological analysis of articular cartilage; (2) techniques for seg-
menting cartilage; (3) semi-quantitative scoring of cartilage status; and (4) technical validity (accuracy), precision (reproducibility) and sensi-
tivity to change of quantitative measures of cartilage morphology.
Results: Semi-quantitative scores of cartilage status have been shown to display adequate reliability, speciﬁcity and sensitivity, and to detect
lesion progression at reasonable observation periods (1e2 years). Quantitative assessment of cartilage morphology (qMRI), with fat-sup-
pressed gradient echo sequences, and appropriate image analysis techniques, displays high accuracy and adequate precision (e.g., root-
mean-square standard deviation medial tibia¼ 61 ml) for cross-sectional and longitudinal studies in OA patients. Longitudinal studies suggest
that changes of cartilage volume of the order of 4% to 6% occur per annum in OA in most knee compartments (e.g., 90 ml in medial tibia).
Annual changes in cartilage volume exceed the precision errors and appear to be associated with clinical symptoms as well as with time to
knee arthroplasty.
Conclusions: MRI provides reliable and quantitative data on cartilage status throughout most compartments of the knee, with robust acquisi-
tion protocols for multi-center trials now being available. MRI of cartilage has tremendous potential for large scale epidemiological studies of
OA progression, and for clinical trials of treatment response to structure modifying OA drugs.
ª 2006 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.






Diarthrodial (synovial) joints are central organs of the mus-
culoskeletal system and provide the body with the ability to
maintain posture, move through space, and manipulate ob-
jects within the immediate environment. During these activ-
ities, joints commonly encounter forces of several times
their body weight1. Normal joints are able to deal with
such mechanical loads for many decades, but this requires
the numerous tissues and structures that make up these
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2006.A4remarkable organs to act in a tightly orchestrated fashion
and to repair and renew themselves continuously. Hyaline
cartilage, which lines the surfaces of diarthrodial joints, is
critical to normal articular function, and is capable of trans-
ferring and distributing impressive forces without sustaining
substantial wear2,3. Moreover, articular cartilage provides
an almost frictionless gliding surface, so that these forces
can be transmitted during dynamic joint activity4e11. In order
to meet these complex functional demands, articular carti-
lage displays unique morphological features and biome-
chanical properties2,3,10,12,13 that remain unmatched by
any man-made material, despite considerable efforts by en-
gineers and biologists over the years14,15.
Destruction and eventual loss of articular cartilage are be-
lieved to be crucial elements in the pathophysiology of os-
teoarthritis (OA)16, although whether these changes
precede, accompany, or result from changes in other tis-
sues, such as subchondral bone, is still debated16e29.6
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nerves, and therefore can be damaged without any directly
associated pain30e32. However, in one study it was shown
that only the degree of cartilage pathology (as rated from
magnetic resonance [MR] images) was associated with clin-
ical symptoms (i.e., the amount of pain, stiffness and limited
function) in patients with OA, whereas other image features
determined from MR images or conventional radiographs
were not33. Sowers et al.19 reported that women with full-
thickness cartilage defects accompanied by subchondral
bone defects, and those with bone marrow changes
>1 cm, were signiﬁcantly more likely to suffer from painful
OA than those without. Preventing the breakdown of this tis-
sue is thus believed to be of critical importance to preserv-
ing the functional integrity of any joint. Up to the present
day, no generally accepted medical therapy is available
for preventing cartilage loss in OA. However, a number of
putative therapeutic agents and surgical procedures that
are currently under development show great promise in
this regard, and have renewed the hope of controlling the
progression of this debilitating disease one day14,15,34e52.
An important obstacle to this development has been the
absence of validated, non-invasive methods of quantifying
articular cartilage53e56. Although substantial advances
have been made with radiographic techniques over the
last decade56e62, these have been fundamentally limited
by radiography’s inability to delineate cartilage directly.
Moreover, radiography is a projectional technique, which
collapses three-dimensional (3D) anatomy into 2D im-
ages61,63. The associated morphological distortion and
magniﬁcation complicates dimensional measurements and
makes patient positioning a critical issue, particularly in
multi-center trials. Even with optimal technique, accurate
quantitative measurements of joint-space width (JSW) are
limited to the medial femorotibial (FT) compartment64, and
it is not possible to distinguish femoral from tibial cartilage
loss within the joint. Moreover, recent evidence suggests
that meniscal subluxation can also contribute to joint-space
narrowing (JSN)65,66 independent of cartilage status, and
since the medial and lateral FT compartments are physi-
cally connected, narrowing of one compartment can result
in widening of the other, adding further complications to ap-
propriate interpretation.
In contrast to radiography, magnetic resonance imaging
(MRI) is capable of directly visualizing the articular cartilage.
Because of its thin and geometrically complex morphology,
its relatively short transverse relaxation time (T2), and the
various potential sources of artifacts, particularly at its inter-
face with bone, however, cartilage presents a signiﬁcant
challenge to imaging with MR. The challenges are even
greater in OA, as signal changes, surface ﬁbrillation, tissue
thinning, and the appearance of repair tissue and osteo-
phytes make delineation of the articular cartilage more difﬁ-
cult. Nevertheless, signiﬁcant advances in MRI and digital
image analysis technology have revolutionized non-inva-
sive assessment of cartilage macro-morphology, i.e., vol-
ume and thickness. These techniques have provided
important new insights into the physiological determinants
of cartilage morphology and have enabled systematic as-
sessment of the impact of various factors on normal knee
cartilage morphology, including sex67e71, maturity and
age69,71e77, body weight and height63,67,69,71,73,74,78e80,
body mass index (BMI)77, leg length and foot size80, knee
bone size63,67,69,71,78,79, bone mineral density20, muscle
cross-sectional area74,81, muscle mass82, limb domi-
nance81, level of physical exercise69,71,75e77,83e88, knee
adduction moment89, estrogen replacement90e92, serumtestosterone77, and genetics21,93e95. MRI further offers
a unique opportunity to characterize cartilage loss in OA
and other disorders of articular cartilage, and to evaluate
potential effects of medical or surgical treatment on disease
progression, in clinical research and eventually clinical
practice54,55,61,96.
Clinical studies on pharmacological agents for treatment
of OA have thus far focused on relief of joint pain and im-
provement of joint function, as assessed by self-adminis-
tered questionnaires, e.g., WOMAC97. However, there is
growing interest in evaluating the capability of pharmaco-
logical agents to inhibit pathological processes related to
structural changes of the joint, particularly the breakdown
of articular cartilage. These agents are commonly referred
to as ‘‘disease’’ or ‘‘structure’’ modifying OA drugs
(DMOADs or SMOADs)37,43,44,48,98e100. Although the rela-
tionship between structure modiﬁcation and long-term
symptomatic improvement in OA remains poorly deﬁned
at present, there is a growing acceptance of structure mod-
iﬁcation as an independent therapeutic objective in the
treatment of this disease.
The ability to detect and verify structural treatment re-
sponse to such drugs in OA with a given imaging technique
depends on a number of factors:
(1) The technique employed must measure a biomarker
(a characteristic that is objectively evaluated as an in-
dicator of normal biological processes, pathogenic
processes, or pharmacologic responses to a thera-
peutic intervention) e in this case an imaging bio-
marker e which was evaluated for its ability to
detect structural change. Additionally, in order to be
used as a surrogate for the clinical outcome of the dis-
ease (features that are directly related to how a patient
feels, functions, or survives)54,96, this biomarker
should lie directly on the disease pathway and regis-
ter the relevant beneﬁcial and/or adverse effects of
the drug (‘‘surrogate’’ validity).
(2) The technique should be able to measure the imaging
marker with high accuracy (‘‘technical’’ validity),
where ‘‘accuracy’’ refers to the degree to which the
measurement, e.g., MRI cartilage volume, corre-
sponds to the true value. Ideally, this should be veri-
ﬁed with one or several techniques, a so-called
‘‘gold’’ standard, that has established accuracy.
(3) The ability to detect a signiﬁcant treatment response
in a given number of patients over a given time inter-
val (the statistical power) is determined by the biolog-
ical rate of change of the imaging marker, the extent
to which the rate of change is modiﬁed by the inter-
vention (effect size), and the precision (reproducibil-
ity) of the technique in measuring the marker.
Precision is deﬁned as the ability to reproduce mea-
surements under conditions in which the measured
marker is constant. Sensitivity to change is, therefore,
a function of the ratio of the expected change for
a given marker to the precision error for measuring
the marker. Note that the former is determined by
the nature of the disease and is not affected by the
particular technique employed, although in principle
it is possible to design studies where large change
is expected by selecting particular patients or by fo-
cusing measurements only in particular locations.
In the above context, the following report reviews the cur-
rent state of the art for semi-quantitative and quantitative
assessment of articular cartilage morphology using MRI.
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morphological analysis of articular cartilage
Currently available MRI pulse sequences for cartilage
analysis are reviewed in the current supplement of Osteoar-
thritis & Cartilage (Gold et al.). To be suitable for quantita-
tive assessment of cartilage status, MR sequences must
fulﬁll the following requirements:
(1) Signal-to-noise ratio (SNR), contrast-to-noise ratio
(CNR), and artifacts: There must be sufﬁcient SNR
and CNR to accurately delineate the boneecartilage
interface and the articular surface both in healthy
and diseased joints. Also, there should be no signiﬁ-
cant artifacts (geometric distortion or signal distor-
tion101). Artifacts are particularly common at the
bone cartilage interface, where fat-bound and water-
bound protons abut.
(2) Spatial resolution: Because articular cartilage is only
1.3e2.5 mm thick in healthy knees63,73 and even thin-
ner in knees with OA, relatively high spatial resolution
is required to ensure a sufﬁcient number of image
points (pixels) to measure cartilage thickness accu-
rately and precisely (typically a slice thickness of
2 mm with a pixel size of 300 mm).
(3) Image acquisition time: Images must be acquired
within reasonable examination times (<20 min per
pulse sequence, <75 min per imaging session), in or-
der to avoid movement artifacts, maintain patient
comfort, and contain costs.
It is important to note that SNR/CNR, acquisition time,
and spatial resolution are interdependent, and optimizing
one of these parameters at a given ﬁeld strength necessi-
tates sacriﬁces in the others. Increasing spatial resolution
by a factor of 2 in all three dimensions, for instance, re-
quires a 64-fold increase in acquisition time, if the SNR is
to be kept constant. Therefore, a delicate balance has to
be achieved among these parameters for optimal delinea-
tion of a given joint or joint surface with a speciﬁc MR
sequence.
In a systematic comparison of images with different in-
plane resolutions, Hardy et al.102 reported signiﬁcantly
larger precision errors for cartilage volume measurements
derived from the lower-resolution (0.55 mm 0.55 mm)
images than for those from the higher-resolution
(0.28 mm 0.28 mm) images in the femur and tibia (see
Table VI), despite considerably lower SNR and CNR of
the higher-resolution images. Based on an analysis of arti-
ﬁcial cartilage lesions in rabbit joints, Link et al.103 similarly
showed that the ability to detect small lesions critically de-
pended on spatial resolution, and that achieving a high res-
olution justiﬁed some degree of sacriﬁce in SNR. Note that
the in-plane resolution can be chosen asymmetrically104,105
with larger dimensions in the phase encoding direction. This
permits substantial reduction in acquisition time, but the ef-
fect on accuracy and precision of quantitative cartilage
measurements has not yet been determined in comparative
studies.
As image voxels can be aligned with their shortest dimen-
sion perpendicular to the joint surface, section thickness is
less critical than in-plane resolution, but still an important
consideration. Marshall et al.104 compared volumes calcu-
lated from images acquired with different section thickness
with the actual volume of phantoms, and reported a mean
difference of 1.7 1.3% for 1.0 mm section thickness,
3.5 2.5% for 1.5 mm, 6.4 2.5% for 2 mm, and23 1.9% for 3 mm slice thickness. They recommended
use of a 1.5 mm section thickness, because of the long im-
aging time required with thinner slices. Hardy et al.102 re-
ported no signiﬁcant difference in the inter-scan precision
of cartilage volume measurements in the human femur,
tibia, and patella at different section thickness (0.5 mm,
1 mm, 2 mm) (see Table VI). Cicuttini et al.106 found an in-
crease in slice thickness (1.5e7.5 mm) to have little effect
on absolute cartilage volume estimates in the medial and
lateral tibia (sagittal orientation) and the absolute rate of
longitudinal change in a cohort studied over 2 years (see
below). However, the increase in slice thickness was simu-
lated by analyzing each second, third, fourth and ﬁfth slice
(with a 1.5 mm slice thickness), which displays less partial
volume effects than slices truly obtained with 3, 4.5, 6 and
7.5 mm thickness, and there was a decrease in correlation
(lowest r¼ 0.77 for lateral tibial cartilage) when looking at
the rate of change with a simulated 7.5 mm slice thickness
compared with 1.5 mm. Similar observations were made in
another population sample107. Although there is no current
consensus on the optimal resolution for imaging knees in
OA, 1.5 mm section thickness and 0.3 mm in-plane resolu-
tion has commonly been used, as these allow total cover-
age of the knee in imaging times of 10e12 min.
The MR sequences that have been most commonly used
for cartilage quantiﬁcation over recent years have been fat-
suppressed T1-weighted spoiled gradient echo (Fig. 1). Dif-
ferent MRI vendors name these sequences differently
(FLASH¼ fast low angle shot108, SPGR¼ spoiled gradient
recalled acquisition at steady state), but they are otherwise
very similar and are available on most whole-body clinical
MRI systems with 1.0 Tesla (T) magnetic ﬁeld strength.
One group109e111 currently favors a refocused (fast imaging
at steady-state precision¼ gradient recalled acquisition at
steady state) rather than a spoiled GRE sequence. This
approach involves slightly longer acquisition times but still
provides good contrast between cartilage and adjacent
structures.
An important component of all of these gradient echo se-
quences is fat suppression. This is accomplished either by
spectral fat saturation using a prepulse tuned to the reso-
nant frequency of fat105,112e114 or more recently by fre-
quency selective water excitation115e119. Fat suppression
is required to provide a sufﬁcient dynamic range to the im-
age contrast to delineate the cartilage, but also to eliminate
chemical-shift artifacts, which arise at the cartilageebone
interface (for details see Gold et al., same issue). Acquisi-
tion times are generally shorter for selective water-excita-
tion protocols than for those using spectral fat
suppression, as the latter requires an additional pulse at
the beginning of the sequence.
Most studies on morphological assessment of articular
cartilage with MR imaging were so far performed with
whole-body scanners at a ﬁeld strength of 1.5 T. Peripheral
(extremity) magnets have the advantage of lower installa-
tion and management costs as compared with whole-body
systems, and thus potentially can be used more widely,
and they avoid the issue of claustrophobia120,121. However,
not all of them are suitable for quantitative assessment of
cartilage morphology. One dedicated 1.0 T peripheral sys-
tem was recently used for semi-quantitative scoring of
cartilage122 and quantitative assessment of cartilage
morphology123, and results will be reported below. On the
other hand, the higher ﬁeld strength of new 3.0 T whole-
body magnets can be employed to achieve higher S/CNR,
higher resolution, or shorter acquisition time124e130. Since
T1 and T2 relaxation times of musculoskeletal tissues are,
A49Osteoarthritis and Cartilage Vol. 14, Supplement AFig. 1. MR images acquired with a T1-weighted SPGR or FLASH se-
quence with water excitation at 1.5T; resolution 1.5 mm (section thick-
ness) 0.3 mm 0.3 mm (in-plane resolution): sagittal image (top),
coronal image (middle), and axial image (bottom). The images were
acquired in collaboration with Prof. David Felson, M.D., M.P.H.
(Arthritis and Musculoskeletal Disease Center, Boston University,
Boston, MA).however, different at 3.0 T and artifacts may be enhanced,
protocols at higher ﬁeld strength need to be optimized and
validated. At 3.0 T, Kornaat et al.126 found the SNR and
CNR efﬁciency for cartilage to be increased by a factor of
1.8 vs 1.5 T for SPGR sequences, and by a factor of >2
by steady-state free precession sequences.
Semi-quantitative scoring of articular
cartilage defects
A number of semi-quantitative scoring methods have
been developed for MR images of articular cartilage. Most
of these methods grade the severity of cartilage thinning
from 0 to 3 or 4 based on subjective evaluations by one
or more experienced radiologists. A relatively high speciﬁc-
ity and sensitivity for detecting chondral lesions was demon-
strated in cadaveric knees and in vivo with arthroscopic
veriﬁcation for fat-suppressed T1-weighted SPGR112,131,132.
Similar results were found with fat-suppressed T2-weighted
fast spin echo (FSE)133,134, which requires much less imag-
ing time, and also recently for selective water-excitation
SPGR135 and fat-suppressed driven equilibrium Fourier
transform imaging136. Bredella et al.137 reported sensitiv-
ity/speciﬁcity values of 61%/99%, 59%/99% and 40%/
100% for detecting chondral lesions in the coronal, axial
and sagittal plane, respectively, but 93%/99% when axial
and coronal images were combined, and 94%/99% when
images in all three planes were combined. In this study, ac-
curacy was highest for severe cartilage lesions and lowest
for minor lesions, particularly for signal intensity alterations.
Recently, Masi et al.127 used a porcine model with artiﬁcial
cartilage lesions to compare the accuracy of lesion depic-
tion for intermediate-weighted FSE and spoiled gradient
echo sequences acquired at 1.5 T and 3.0 T. The highest
lesion detection rate was achieved with the intermediate-
weighted FSE sequence at 3.0 T (90% vs 62% at 1.5 T),
whereas the most accurate assessment of lesion grade
was obtained with the SPGR sequence acquired at 3.0 T
(83% vs 70% at 1.5 T). Receiver operating characteristic
analyses in the same model conﬁrmed improved diagnostic
performance in detecting cartilage lesions at 3.0 T, but only
if high-resolution imaging protocols (slice thickness 2 mm
and in-plane resolution 0.39 mm) were used128.
Peterfy and colleagues recently described a scoring sys-
tem in which cartilage lesions are graded according to both
depth and extent (Fig. 2) along the joint surface using an
eight-point scale. This score is part of a more comprehen-
sive scoring system (whole-organ MRI scoring), in which
multiple features (14) are graded within the knee138e140.
To systemize the approach, cartilage lesions are graded
in 15 distinct regions of the knee. Despite the complexity
of the system and the expanded scale (eight-point) for car-
tilage and osteophytes, the inter-observer agreement (intra-
class correlation coefﬁcient¼ ICC) among two trained
readers was high (>0.98 for cartilage abnormalities and
>0.80 for most features, except for bone attrition and syno-
vitis). This system was recently also applied to MR images
obtained with a 1.0 T dedicated extremity MRI system122.
Another compartment based scoring system termed knee
OA scoring system was published, with intra-observer re-
producibility of 0.76e0.96 (ICC) and inter-observer repro-
ducibility amongst two independent observers of
0.63e0.91141.
Biswal et al.142 examined 43 patients (age 17e65 years),
comprised of 21 with sport related injuries, 10 with acciden-
tal falls or vehicle accidents, four with OA, and ﬁve with joint
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peat MRI of the knee at intervals of 1e5 years (average 1.8
years). Proton density-weighted FSE and fat-suppressed
T2-weighted FSE images were read by three readers who
were initially blinded to the order of acquisition (baseline
vs follow-up). Eventually, however, a consensus interpreta-
tion was formulated, in which images were read side by side,
and in which the order of acquisition was revealed. Cartilage
lesions were graded according to the scoring system out-
lined in Fig. 2: 147 lesions were prevalent at baseline,
36% were grade 1A, 16% grade 1B, 25% grade 2 or 3,
and 23% grades 4e6 (Table I). Of these, 12% were not de-
tectable at follow-up, 6% changed to a lower grade (exclud-
ing those that disappeared), 32% remained the same, and
50% progressed toward higher grades (Table I). In addition,
84 new lesions occurred during the observation period.
Grade 1A lesions apparent at baseline tended to progress
toward ﬁssuring (grade 3A), whereas grade 1B lesions
tended to progress toward cartilage thinning (grades 4e6).
Although the structural basis of grade 1 lesions (signal het-
erogeneity) is unknown, this study indicates that a substan-
tial proportion of these lesions progress toward
morphological abnormality. On the other hand, a percentage
Fig. 2. Eight-point scale for the semi-quantitative scoring of articular
cartilage signal and morphology. Each of 14 regions of the knee
surface is scored independently according to the following scheme:
0 ¼ normal thickness and signal; 1 ¼ normal thickness but in-
creased signal on T2-weighted MR images; 2.0¼ partial-thickness
focal defect <1 cm in greatest width; 2.5¼ full-thickness focal de-
fect <1 cm in greatest width; 3¼multiple areas of partial-thickness
(grade 2.0) defects intermixed with areas of normal thickness, or
a grade 2.0 defect wider than 1 cm but <75% of the region;
4¼ diffuse (75% of the region) partial-thickness loss; 5¼multiple
areas of full-thickness loss (grade 2.5) or a grade 2.5 lesion wider
than 1 cm but <75% of the region; 6¼ diffuse (75% of the region)
full-thickness loss. The maximum cartilage scores for the medial FT
joint, lateral FT joint, PF joint and the entire knee are 30, 30, 24 and
84, respectively.of grade 1 lesions disappeared during the study period. It re-
mains unclear whether this is due to technical inability to
reconﬁrm lesions on follow-up examination, or to actual
healing or repair. Seventy-one percent of the baseline
lesions were seen medially, and 29% in the lateral compart-
ment (Table II)142. The incidence of new lesions (n¼ 44)
was also higher medially (59%) than laterally (41%). Lesions
in the central medial FT compartment were signiﬁcantly
more likely to progress to higher grades than those in the
anterior and posterior medial FT compartment (Table
II)142. Subjects with meniscal tears and ACL repair tended
to display a higher rate of progression than those without142.
Knee cartilage defect severity, as measured from sagittal
T1-weighted fat-suppressed SPGR sequences, has been
shown to be signiﬁcantly associated with urinary levels of
C-terminal cross-linking telopeptide of type II collagen in
a convenience sample of 372 male and female subjects
aged 26e61 years143. In the same sample, cartilage de-
fects were signiﬁcantly associated with age, but the associ-
ation decreased in magnitude when adjusting for
radiographic OA (ROA)144. An association was also re-
ported between cartilage defects and BMI145.
In 86 healthy subjects, cartilage lesions were observed to
increase more in males than in females over a 2 year
period, but baseline cartilage defect scores were negatively
associated with defect progression146. This may be ex-
plained by regression of cartilage lesions with highest
defect scores in healthy subjects, or by methodological lim-
itations including overclassiﬁcation of lesion severity in
some baseline MRI scans that are not reproduced at fol-
low-up (i.e., regression to the mean).
In a sample of 224 men and women with symptomatic
knee OA, Amin et al.147 reported cartilage loss (deﬁned
as an increase in a semi-quantitative MRI cartilage grading
score) to be signiﬁcantly associated with semi-quantitatively
graded JSN of weight-bearing radiographs in the FT joint,
but there was a substantial pro-portion of knees (42%) in
which cartilage loss was detected with MRI but no radio-
graphic progression was observed. Defect progression
occurred frequently in the central regions of the tibia and
femur, but also in the posterior femur, with the latter being
less likely reﬂected by radiographic change.
In a sibpair study of 115 subjects followed over 2.4 years,
Zhai et al.148 found the adjusted heritability estimates for the
progression of cartilage defects to be 98% for the medial
and 80% for the lateral FT compartment. In a sample of
117 subjects with symptomatic knee OA, those with higher
total cartilage defect scores (8) at baseline were associ-
ated with a 6.0-fold increase risk of joint replacement 4
years later compared with those with lower cartilage defect
scores (7)149.Table I














(to 1B 2e3 4e6)
1A 53 (36%) 25 e 15 60 (19% 30% 11%)
1B 24 (16%) 21 4 46 29 (e 8% 21%)
2e3 37 (25%) 0 8 35 57
4e6 33 (23%) 0 12 46 42
Total 147 (100%) 12 6 32 50
For scores, see Figure 2. 1A ¼ <1 cm2, 1B ¼ >1 cm2
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morphology and techniques for segmentation
and analysis
PARAMETERS
There has been a great demand for quantitative parame-
ters of cartilage macro-morphology and cartilage loss which
are continuous variables, as opposed to the categorical vari-
ables provided by scoring systems. For research aimed at
understanding cartilage physiology and pathophysiology,
and for evaluating response to treatment, continuous vari-
ables can be expected to exhibit better statistical power
than categorical variables characterizing the same bio-
marker. These parameters providing continuous variables
include cartilage volume, cartilage thickness, cartilage sur-
face area (or bone cartilage interface, as a measure of meta-
physeal bone size), percent cartilaginous (or denuded) joint
surface area, cartilage surface curvature (joint incongruity),
lesion size and depth, and others. Cartilage volume is a func-
tion of cartilage thickness and cartilage surface area. There-
fore, changes in cartilage volume can be caused by either an
increase or decrease in cartilage thickness or a change in
cartilaginous surface area, such as an increase of denuded
joint surface area. Speciﬁc algorithms are required to differ-
entiate between these factors (see next section). It has been
shown, for instance, that gender differences in joint surface
areas are substantially greater than those for cartilage thick-
ness68, a ﬁnding that is not evident from measuring cartilage
volume alone67. Also, it has been shown that cartilage thick-
ness and joint surface area are not strongly associated in
healthy joints79. Therefore, each of these parameters must
be measured independently.
Delineation of the cartilage surface also permits determi-
nation of the geometric topography and curvature of diarthro-
dial joints150. In order to obtain a geometric model of the
surface and to describe its curvature characteristics (e.g., in-
congruity with the articulating surface) comprehensively, it
is necessary to provide a mathematical description of the
surface. This can be achieved, for example, by ﬁtting
Table II
Prevalence, incidence, and progression of cartilage lesions in differ-

































*Numbers differ from those given in paper, because percentages
for the current table were calculated based on number of lesions in
the FT joint only, but not based on numbers in the total knee.continuous B-spline surfaces through discretely segmented
surface points151e153. The principal curvatures can then be
calculated from the Weingarten-transformation of the inter-
polated B-spline surface, and are identical to the Eigen-
values of the Weingarten-matrix153. By computing an
equivalent surface from two contacting cartilage layers, it is
then possible to derive a quantitative measure of joint incon-
gruity along the least and most congruent directions as well
as for the total surface153,154. Using high-resolution MRI,
Hohe et al.153 reported the incongruity of the human patello-
femoral (PF) joint (Ke RMS¼ 79.7 6.6 m1) to be signiﬁ-
cantly greater than that of the lateral (47.2 10.5 m1)
and medial (33.8 13.6 m1) FT compartments. Similar
methods have been applied to characterize the donor and
recipient sites in osteochondral autograft surgery of the
knee155. Mathematical description of joint surfaces and artic-
ular cartilage layers can also be applied to derive computer
models of human joints by which cartilage contact areas and
surface stresses can be estimated152,156. These techniques
also permit simulation and optimization of surgical proce-
dures157,158 tailoring them to the individual patient.
SEGMENTATION
To derive quantitative data from sequential, contiguous
images, the anatomical structure of interest (articular carti-
lage) must ﬁrst be isolated from neighboring structures,
i.e., segmented. Due to the relatively low contrast in some
areas of the joint surface (e.g., articular contact areas,
areas adjacent to synovial folds, muscle, tendons, liga-
ments, Hoffa’s fat pad, and repair tissue), fully automated
segmentation of cartilage from MR images has not yet
been achieved. Various semi-automated segmentation
techniques have been developed (Table III) that require dif-
ferent degrees of user interaction. Veriﬁcation (and some
degree of correction) by an experienced user is generally
necessary on a section-by-section basis. The inability of
computer software to reliably identify structures in images
that are evident to the experienced human ‘‘eye’’ may
seem surprising. However, if one considers the great difﬁ-
culties involved in automated speech recognition by digital
computers e despite the tremendous efforts made by in-
dustry e one may appreciate the complexity involved in
the automated recognition of complex patterns. For these
reasons, and because many slices of one joint surface
have to be examined in order to obtain sufﬁcient spatial res-
olution, cartilage segmentation is currently extremely time
consuming, generally requiring one to several hours per
knee data set, by a trained reader.
Ideally, semiautomated (interactive) algorithms should
provide similar or greater accuracy and reproducibility
than manual methods do, but with less time, effort and
need for special expertise159. Because the algorithms
may be inaccurate, validation against independent, estab-
lished methods is recommended. Ideally, validation should
be based not only on phantoms but the actual biological
structure of interest (see next section). The reason for this
is that some sources of artifact in MRI occur only when
the actual tissue is placed in the magnetic ﬁeld. As outlined
in Table III, a number of algorithms have been validated in
this fashion.
QUANTITATIVE ANALYSIS
After segmentation, computation of the cartilage volume
is relatively straight forward. This is achieved by simply
A52 F. Eckstein et al.: qMRI for assessment of cartilage morphology in OAsumming the voxels attributed to the segmented cartilage
[Fig. 3]. If the in-plane resolution is low, it may be necessary
to mathematically smooth the ‘‘pixilated’’ boundaries of the
cartilage, because of the high surface-area-to-volume ratio
of this structure. Another way to deal with this is to make
use of ‘‘sub-pixel resolution’’ and interpolate the data to
a higher in-plane resolution prior to segmentation. This
has been done, for instance, to reduce imaging time for spe-
cial purposes160, or analyze joints with very thin carti-
lage87,117,161. However, it should be kept in mind that
interpolation to a smaller pixel size is not equivalent to ac-
quiring image data with high resolution.
Cartilage volume (Fig. 3), however, provides only a ﬁrst
step in the analysis of cartilage morphology. More compre-
hensive information can be derived from separating the car-
tilage volume into its two factors, namely the cartilage
thickness and the size of joint surface area.Methods for com-
puting these parameters have been developed by several
groups (Table IV). Because sectional images cannot be
aligned perfectly perpendicular to all parts of the joint sur-
face, computations of the cartilage thickness and the size
of the joint surface area should account for out-of-plane de-
viations of the relevant distances or areas. These should
thus be performed in 3D and be independent of the original
sectional orientation114,162. As described above, mathemat-
ical descriptions of articular cartilage surface topography can
be derived by ﬁtting B-spline surfaces to the segmented data.
Because these ‘‘general’’ parameters (volume and mean
thickness for an entire cartilage plate) may be relatively in-
sensitive to regional/focal changes, several investigators
developed techniques for displaying regional thickness pat-
terns114,152,163e169. These techniques were also applied to
the detection of cartilage lesions166,168,170. However,
changes in cartilage thickness are difﬁcult to detect from
subjective comparison of thickness patterns obtained at dif-
ferent points in time, particularly because only a limited
number of thickness intervals can be displayed with a limited
Table III
Approaches to cartilage segmentation by various groups
Authors Method Validation by
Peterfy et al.113 Region growing Water displacement
of SRT113
Piplani et al.236 Region growing Water displacement
of SRT236
Eckstein et al.114,166 Region growing CT arthrography114,166
Solloway et al.237 Active shape
models
Manual segmentation237
Kshirsagar et al.171 Edge detection e





















Steines et al.239 Live wire algorithm e
Lynch et al.240 Active contours e
Kauffmann et al.109 Active contours Synthetic 3D
MR images109
Gougoutas et al.241 Live wire algorithm Phantom
SRT¼ surgically retrieved tissue.number of color codes or gray levels. In order to track local/
regional thickness changes over time, registration tech-
niques were proposed110,171e175. With these methods, the
bone interfaces from two data sets are ‘‘matched’’, so that
the thickness distribution can be compared on a point-by-
point basis. Kshirsagar et al.171 suggested that analyzing
subvolumes within the joint surface by such techniques
can reduce precision errors relative to those from analyses
of the entire cartilage plate and this was recently conﬁrmed
by a study by Koo et al.169 for the central weight-bearing re-
gions of the femoral condyles. When matching thickness
patterns of entire joint surfaces, Stammberger et al.172 pro-
posed an algorithm that combines principal axis decompo-
sition to achieve alignment, and elastic deformation
(according to criteria of surface parallelity and Euclidean
distance) to optimize tracking of anatomically identical sur-
face points. They reported local precision errors of cartilage
Fig. 3. 3D reconstructions of femorotibial articular cartilage as
obtained by segmentation of serial MR image data.
A53Osteoarthritis and Cartilage Vol. 14, Supplement Athickness that range from 0.5 mm to 1 mm, when the joint
was repositioned between acquisitions. These local errors
are relatively large in comparison with the average cartilage
thickness in knee joint surfaces, but they are not surprising,
given the geometric complexity of the structure being recon-
structed and registered, and limited number of sectional im-
ages from which the data are obtained.
Cohen et al.167 presented a method of generating tem-
plates of regional cartilage thickness for ‘‘normal’’ cartilage
thickness at the PF joint, based on the statistical averages
of healthy joints. OA patients’ thickness maps were then
matched and compared to the normal templates, in order
to identify regions that most likely represented areas of car-
tilage loss167.
Williams et al.175 constructed a ‘‘Minimum Description
Length Statistical Shape Model (SSM)’’ from the endosteal
bone surfaces from a population of healthy female volun-
teers. An SSM provides a mean shape, represented as
a dense point set and triangular connecting facets, and
modes of shape variation. The facets are propagated, in
an anatomically consistent manor, to any instance of the
model. This model can be used to infer the pre-morbid
extent of cartilage in OA patients with areas of denuded
bone, and a ‘trimmed’ region deﬁned to avoid errors arise
at the edges of articulating surfaces, which are difﬁcult to
segment yet may be involved to only a minor degree in
the disease process.
Also recently, a computer-aided gradient peak method
was proposed for computing the depth, diameter, area,
and volume of cartilage lesions directly176. These measure-
ments were shown to be accurate in a porcine experimental
model as well as in comparison with arthroscopic evaluation
of cartilage lesions177.
Validity (accuracy) of quantitative cartilage
measurements
When deﬁning validity, one needs to differentiate be-
tween the surrogate validity of the marker (e.g., cartilage
Table IV
Approaches to cartilage analysis by various groups
Authors Parameter Method
Mu¨nsterer et al.242 Thickness 2D normal vector method
(from bone interface)
corrected for angulation
Solloway et al.237 Thickness (2D) Medial axis method
Lo¨sch et al.170 Thickness (3D) Minimal distance method
(from cartilage surface)
Cohen et al.152 Thickness (3D) Normal vector method
(from bone interface)
Stammberger et al.203 Thickness (3D) Euclidean distance
transformation (EDT)




Kauffmann et al.109 Thickness (3D) Offset-maps differences
based on 3D
parametric primitives
Raynauld et al.110 Thickness (3D) Normal vector method
(from bone interface)







analysisvolume, cartilage thickness) in predicting patient-relevant
outcome (e.g., worsening of symptoms, increase in func-
tional impairment, time to total knee arthroplasty [TKA],
etc.), and the technical validity for a given measurement
method (the accuracy by which the marker is measured)96.
The technical accuracy of MRI-based measurements was
addressed in a relatively large series of studies in recent
years (Table V). By comparison, there has only been one
validation study of radiographic JSW reported in the litera-
ture64. In that study, JSW derived from semiﬂexed, ﬂuoro-
scopically aligned, weight-bearing radiographs of 20
knees of patients with OA and 14 knees of healthy subjects
were compared with the sum of femoral and tibia cartilage
thickness measured from non-weight-bearing double con-
trast macro-arthrograms. Most validation studies of MRI
have utilized unselected cadaveric joints (Table V), ampu-
tated joints67,113 or knee joints of patients prior to
TKA67,113,118,119. TKA provides a unique opportunity for
validating MRI measurements, since patients can be
imaged in vivo prior to surgery, and the cartilage then
removed and analyzed after the operation. Moreover,
a large range of cartilage destruction can be observed,
with some compartments showing only mild damage, while
others suffering more severe degenerative changes119.
Various established reference methods were used as
a ‘‘gold standard’’ in these studies, including water displace-
ment of surgically retrieved tissue (by weight or volume), di-
rect pathological correlation with anatomical sections
obtained with high precision band saws, CT arthrography,
A-mode ultrasound, and stereophotogrammetry (Table V).
Most of these validation studies reported high agreement
between MRI and the reference standard, with random er-
rors (absolute pairwise over- or underestimation) of approx-
imately 5e10% (Table V). Eckstein et al.166 reported that
the deviation between MRI and CT arthrography was not
greater than that between repeat CT arthrographic exami-
nations with interval repositioning. No consistent over- or
underestimation by MRI relative to the reference methods
was demonstrated across studies. In contrast to radio-
graphic JSW, for which sufﬁcient accuracy was conﬁrmed
only in the medial FT compartment, not in the lateral FT
or the PF compartments64, the degree of accuracy of
MRI-based measurements appears to be similar for all car-
tilage surfaces throughout the knee (Table V). It should
be noted that conventional MRI is non-load-bearing, and
has been validated against other non-weight-bearing
protocols, whereas weight-bearing radiographs may be
inﬂuenced by the effects of cartilage compression and
meniscal extrusion65,66,178.
The generation of cartilage thickness patterns from
MR image data has also been found to be accurate. The
accuracy was established by making a point-by-point
comparison of identical and deviating cartilage thickness in-
tervals in comparison with reconstruction from other
(established) techniques of cartilage thickness measure-
ment114,164,165,179. In the patella, studies found no difference
in accuracy for areas of thinner cartilage than those of
thicker cartilage165,179, whereas Koo et al.169 reported that
the accuracy in central weight-bearing regions of the femoral
condyles was higher than boundary non-weight-bearing
regions. Cohen et al.152 reported accuracy errors at the
articular surface (root-mean-square [RMS] residual er-
ror¼ 0.22 mm) to be slightly larger than those at the
bone interface (RMS residual error¼ 0.14 mm), compared
with stereophotogrammetry. Cartilage thickness displayed
a RMS of the residual error of approximately 0.3 mm in
the knee, which was less than the in-plane resolution
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Peterfy et al.113 sag // 2.0 Volume patella (6)




all (12) 0.31 0.1 ml (5.9%) e 0.99 (8.8%)
Marshall et al.104 sag // 1.5 Thickness med FC (4) 0.06 0.01 mm (3.6%) þ0.7% 0.80
0.3 0.8 Anat. Sect.
[4 exarticulated
bovine knees]
Sittek et al.164 axial // 2.0 Volume patella (1) 0.22 ml (5.6%) 5.6%
0.5 0.5 Thickn. pattern 81% pixels identical thickn.
interval (0.5 mm)
Anat. sect. 14% pixels deviation of 1
interv. (0.5 mm)
[1 cadaver] 5% pixels deviation of 2
interv. (0.5 mm)
Eckstein et al.114 sag // 2.0 Volume patella (6) 0.32 0.17 ml (7.9%) 7.9% (P< 0.05) 0.98
0.3 0.3 Thickn. pattern tot fem (1) 3.8% þ3.8%
Anat. Sect. med tib (1) 4.2% 4.2%
[6 cadavers] lat tib (1) 1.1% þ1.1%
Piplani et al.236 sag // 2.0 / Volume patella (4)







all (14) 0.17 0.15 ml (6.5%) 0.99
Kladny et al.244 cor // 1.1 / Thickness tot tib (14) 0.12 0.28 mm (8.4%) 0.96
? Anat. Sect.
[14 cadavers]
Eckstein et al.179 axial // 1.5 / Thickn. pattern patella (3) 48e52% pixels identical thickn.
interv (0.5 mm)
0.3 0.3 A-mode US 16e35% pixels deviation of 1
interv. (0.5 mm)
CT arthrogr. 11e27% pixels deviation of 2
interv. (0.5 mm)
Anat. Sect. 1e10% pixels deviation of >2
interv. (0.5 mm)
[3 cadavers]
Eckstein et al.166 sag // 2.0 / Volume patella (8) 2.5 2.2% þ2.5% (P< 0.05) 0.99
0.3 0.3 Thickn. pattern tot fem (8) 4.5 2.9% þ3.5% n.s. 0.95
CT arthrogr. med tib (8) 4.3 4.4% þ1.7% n.s. 0.94
[8 cadavers] lat tib (8) 2.2 1.5% 0.8% n.s. 0.98
all (32) 3.3% þ2.6% (P< 0.05)
Cohen et al.152 sag // 1.0/ Mean thickness patella (6) 0.24 0.07 mm (RMS of
residual error)
0.5 0.5 SPG tot fem (6) 0.29 0.10 mm
[6 cadavers] tot tib (6) 0.41 0.15 mm
all (18) 0.31 0.09 mm
Cicuttini et al.67 sag // 1.5/ Volume patella (10) 0.2 0.1 ml (8.8%)
0.3 0.3 WDSRT tot fem (6) 0.6 0.1 ml (9.2%)
[10 cadavers 3
amputations 3 TKA pat.]
tot tib (4) 0.4 0.1 ml (9.2%)
Eckstein et al.184 sag Mean thickness patella (8)
axial CT arthrogr. axial 5.9% 1.4% (n.s)
cor sag 5.1% 3.9% (n.s.)
// 1.5 / med tib (8)
0.3 0.3 cor 17.4% 14.7% (n.s.)
sag 17.9% 17.7% (n.s.)
lat tib (8)
cor 10.4% 10.4% (P< 0.05)
sag 13.7% 13.7% (P< 0.05)












Cicuttini et al.105 sag // 1.5/ Volume tot fem (1) 0.2 ml (2.0%) þ2.0%
0.3 0.6 WDSRT tot tib (1) 0.14 ml (3.2%) 1.4%
[1 amputation]
Burgkart et al.118 cor // 1.2/ Volume med tib (5)
0.3 0.3 WDSRT lat tib (4)
[8 TKA pat.] all (9) 0.15 ml (13%) 13% (P< 0.01) 0.98 (7%)
Graichen et al.119 cor // 1.5 % Cart. surface medþ lat
0.3 0.3 Image analysis tib(41) 4.6 5.1% 0.7% (n.s.) 0.97 (5.6%)
Mean thickness patellaþmed
Anat. Sect. þlat tib (29) 8.9 8.0% 2.2% (n.s.) 0.92 (9.6%)
Volume patellaþmed
WDSRT þlat tib (27) 9.1 7.5% þ2.2% (n.s.) 0.98 (11%)
sag¼ sagittal; cor¼ coronal; resolution given as // section thickness / in-plane resolution; thickn.¼ thickness; WDSRT¼water displace-
ment of surgically removed tissue; anat. sect.¼ anatomical sections; US¼ ultrasound; arthrogr.¼ arthrography; SPG¼ stereophotogramme-
try; tot¼ total; med¼medial; lat¼ lateral; tib¼ tibia; tot fem¼ total femur including the trochlea and both condyles; FC¼ femoral condyle; fem
tro¼ femoral trochlea; Correl. r¼Pearson correlation coefﬁcient [note that correlation coefﬁcients depend on the range of values observed
and cannot therefore be compared between studies]; SEE¼ standard error of the estimate (in %). *P< 0.05; **P< 0.01.(0.5 mm). In a recent report, Graichen et al.119 demonstrated
that, in patients with severe OA (prior to TKA), the percent-
age of joint surface covered with cartilage e or conversely
the denuded joint area e as well as the thickness of the re-
maining cartilage layer could be determined accurately with
MRI (Table V). Note that each of these parameters (cartilage
thinning and articular surface denuding) represents different
processes leading to decreased cartilage volume.
Because of the relatively short T2 relaxation times in ar-
ticular cartilage, especially in deep cartilage adjacent to
the bone interface180e183, MR sequences for quantitative
measurements should be used with as short an echo time
(TE) as possible, preferably below 10 ms. Eckstein
et al.184 reported a signiﬁcant underestimation of tibial, but
not patellar, cartilage thickness compared to CT arthrogra-
phy, when using a fat-suppressed T1-weighted GE se-
quence with a TE of 11 ms. Cartilage volume and
thickness measurements from MR images acquired with
a fat-selective pre-pulse correlated linearly with those de-
rived from images acquired with selective water excita-
tion116. Values were approximately 4% higher for the water-
excitation protocol, but this fact was attributed to the shorter
TE (TE¼ 6.6 vs 11 ms) attainable with water excitation
rather than to the methodological difference in generating
fat suppression. It is particularly important to avoid this con-
founding effect of T2 relaxation on volume measurement in
studies of the progression of OA, otherwise segmentation
artifacts can be mistaken for true changes in volume.
Studies that directly compared the impact of changes in
gradient direction (exchangeof frequency vs phaseencoding
direction) on cartilage thickness165,184 have suggested that
no geometric distortion is involved in quantitative cartilage
measurements, when using high-resolution SPGR/FLASH
sequences. Note that geometric distortion only occurs along
the frequency-encoding direction, but not along either of the
two phase encoding directions101. It was also shown that no
systematic differences for patellar and tibial cartilage volume
and thickness estimates were apparent, when the volumes
were determined from image sets acquired with different sec-
tion orientations (axial vs sagittal, and coronal vs sagittal, re-
spectively) in healthy volunteers184.
Morgan et al.185 compared cartilage volumes from MR
images acquired in the same volunteers with scannersfrom different vendors and at different imaging sites. They
found only small systematic differences and concluded
that it is feasible to use different scanners in a multi-center
study. Hudelmaier et al.186 also found systematic (albeit
small) offsets for cartilage volume and thickness measure-
ments between different scanners from the same vendor,
and also for different implementations of an SPGR/FLASH
sequence on the same magnet. Although this does not limit
the ability to compare longitudinal changes of cartilage mor-
phology between different participants at different sites (as
long as the same scanner hardware and sequence are
used for baseline and follow-up exams at each site), it
should be noted that this may limit cross-sectional analysis
from multi-center trials to a minor degree.
When comparing morphological cartilage measurements
between a 1.0 T peripheral (extremity) scanner (SPGR fat
saturated sequence at a 1.5 mm 0.31 mm 0.62 mm res-
olution interpolated to 0.31 mm 0.31 mm in-plane resolu-
tion) and a 1.5 T whole-body magnet (FLASH with water
excitation; 1.5 mm 0.31 mm 0.31 mm), Inglis et al.123
found high agreement between the two systems, with signif-
icant differences observed only in the lateral femur, but not
in the other FT cartilage plates.
Cartilage volume and thickness measurements at 3.0 T
showed only small (non-signiﬁcant) differences as com-
pared with measurements at 1.5 T126,129. In a recent pilot
study for the National Institute of Health OA initiative, a wa-
ter-excitation double echo steady-state (DESS) imaging
protocol at 3.0 T was found to yield values for cartilage vol-
ume and thickness consistent with those obtained with
SPGR at 3.0 T130.
Validation studies were also performed in smaller joints
with thinner cartilage such as the metacarpophalangeal
joint187, the elbow117, the shoulder188, the hip189, and the
ankle190. However, to our knowledge these studies have
so far been conﬁned to 1.5 T.
As mentioned previously, quantitative measurements of
the depth, diameter, area, and volume of cartilage lesions
were validated in a porcine experimental model of OA177.
McGibbon and Trahan168 reported the mean difference
between measured and actual artiﬁcial cartilage defect di-
ameters in the human knee to be less than 0.1 mm,
whereas the lesion depth was underestimated in MRI by
A56 F. Eckstein et al.: qMRI for assessment of cartilage morphology in OA>0.4 mm. Graichen et al.191 created artiﬁcial cartilage de-
fects of various dimensions in human cartilage plates har-
vested during TKA and found the overestimation of the
true defect size with MRI to decrease from 42% in 3 mm de-
fects to only 4% in 8 mm defects.
Precision (reproducibility) of quantitative
cartilage measurements
The precision error is the random variation that occurs
when repeated measurements of a parameter are taken un-
der conditions in which the true value of the parameter is be-
lieved to be constant. Measurement precision is of critical
importance in clinical OA trials, because changes in carti-
lage status occur at a very slow rate. Therefore, highly repro-
ducible techniques are required to resolve these changes
with statistical conﬁdence, and in particular to resolve drug
effects on these changes. Apart from the real change of
the outcome measure in the population and the estimated
effect size of the compound e neither of which is dependent
on measurement methodology e the level of technical preci-
sion has a major impact on the number of patients and the
study duration needed to achieve sufﬁcient statistical power.
Patient number and study duration also impact the cost of
clinical trials, not only directly but also in terms of opportunity
costs associated with delayed entry into the market96. In
addition, there may be ethical limitations to exposing large
numbers of patients to an investigational new agent for pro-
longed periods of time if equivalent information could be
obtained using MRI in a shorter study with fewer patients.
For MRI, precision depends (1) on the process of image
acquisition, and (2) on the process of image analysis and
measurement. In contrast to radiography, differences in
joint positioning are less critical with MRI, because recon-
struction of serial tomographic images preserves 3D ana-
tomical information better than 2D projections do. This
represents a potential advantage for multi-center clinical tri-
als, which require more robust acquisition techniques than
do trials performed at a single specialized center. In order
to test the precision of the technique, the conditions of im-
age acquisition should reﬂect those that apply to clinical
trials. Repeated measurements in cadaver knees, for
instance, are only of limited usefulness, because they do
not account for potential movement artifacts during image
acquisition. Similarly, studies in young healthy volunteers
can only partly predict how well OA patients (possibly obese
and with knee pain) will maintain a consistent position in the
knee coil.
CONDITIONS FOR DETERMINING PRECISION ERRORS
It is important to note that the reproducibility of a tech-
nique can be determined for different conditions:
(a) ‘‘Technical’’ precision: Repeated measurements of
a single image set during one session assess the re-
producibility of the measurement methodology alone.
They do not account for variations that occur during
image acquisition, such as those associated with joint
repositioning. This establishes a ‘‘ceiling’’ for the pre-
cision of the method since all other measurements of
precision incorporate this component.
(b) ‘‘Resegmentation’’ precision: Repeated measurement
of an identical image set in different sessions, days or
weeks apart, assesses the reproducibility of the mea-
surement methodology as well as any drifts intechnical or human performance during the segmen-
tation process. This precision error can have both
random and systematic components.
(c) ‘‘Inter-scan’’ (short term) precision: Measurement of at
least two image sets that were acquired within the
same imaging session but with repositioning of the
joint between repeated acquisitions account for preci-
sion errors associated with image acquisition, particu-
larly joint repositioning, as well as those associated
with the segmentation process. Note that under these
conditions the orientation of the image sections to the
anatomy of interest may vary between image sets,
and that this may increase the error compared with re-
peated measurement of a single image set. Most of
the precision studies that have been undertaken
with MRI adhered to the conditions described here
and have thus evaluated the error for a speciﬁc acqui-
sition protocol in combination with a speciﬁc analysis
software application (Table VI).
(d) ‘‘Long-term acquisition’’ precision: Analysis of at least
two image sets that were acquired during different im-
aging sessions (days or weeks apart) account not
only for the errors introduced by joint repositioning
but also for other factors associated with the image
acquisition process. This includes variability in (1) im-
aging conditions (differences in scanner gradient cal-
ibration due to changes in temperature, humidity, drift,
etc.) and (2) patient conditions (for a more detailed
discussion on this point see below). Long-term preci-
sion cannot be tested in OA patients, but only in sub-
jects for whom cartilage status can be assumed to be
constant. Otherwise, a potential scanner drift cannot
be separated from cartilage loss associated with the
disease process. As for resegmentation precision,
this error may have random as well as systematic
components.
(e) ‘‘Over all’’ precision: Measurement of at least two im-
age sets, acquired during either the same imaging
session (with joint repositioning) or different imaging
sessions, with measurement of the image data in dif-
ferent sessions. This represents the aggregate error
of either bþ c or bD d.
(f) ‘‘Inter-observer’’ precision: When the image analysis is
performed by different observers, additional sources of
error are included, as different readers may have dif-
ferent perceptions about what should and should not
be attributed to cartilage during the segmentation pro-
cess. The inter-observer error can be both random
and/or systematic.
(g) ‘‘Inter-scanner’’ precision: Using different scanners for
the image acquisition or changing the scanner and/or
upgrading its hardware or software during the study
can add further precision error. The inter-scanner dif-
ference is particularly important if it is of systematic
nature.
Note that the relevance of the precision errors under
conditions aeg apply to different study designs.
(1) In a cross-sectional study, in which image acquisition
and image analysis (one single user) are performed
on different days, for instance, it is important to
know the precision errors under conditions b and d.
If, in addition, the data sets are acquired on different
scanners or analyzed by different observers, it is
also important to know the precision errors
Table VI
In vivo reproducibility (intra-observer, inter-scan, image acquisition in one session) for cartilage volume measurements with MRI in the knee by different authors
(SD)* mean/yRMS Upper 95% conf. limit.
(CV%)
.4% (210 ml)y 9.7% (319 ml)
.4% (580 ml)y 13% (1694 ml)
.6% (250 ml)y 11% (370 ml)
.3% (290 ml)* 8.3% (557 ml)
.7% (62 ml)* See below
.8% (66 ml)y 4.3% (156 ml)
.4% (68 ml)* See below
.6% (78 ml)y 1.9% (96 ml)
.3% (46 ml)* See below
.8% (249 ml)* ‘‘
.0% (70 ml)* ‘‘
.4% (95 ml)* ‘‘
.5%y (57 ml) 1.8% (70 ml)
.2%y (75 ml) 3.9% (92 ml)
.8%y 106 ml) 4.7% (130 ml)
.0% (68 ml)y 4.6% (103 ml)
.0% (202 ml)y 3.0% (307 ml)
.0% (152 ml)y 7.6% (231 ml)
.4% (58 ml)y 3.0% (74 ml)
.6% (352 ml)y 3.3% (447 ml)
.6% (68 ml)y 3.3% (86 ml)
.6% (325 ml)y 4.2% (429 ml)
.2% (98 ml)y 4.2% (129 ml)


















































AAuthors Surface Orient Resolution N subjects (type) Repet. (N) CV%
Peterfy et al.113 patella sag 2.0/0.6 0.6 8 (3 amp/5TKA) 2e3 6
tot fem sag 2 4
tot tib sag 2 3
Pilch et al.245 FC sag 1.2/06 0.6 3 healthy vol. 3 4
Marshall et al.104 med FC sag 1.5/0.3 0.8 1 healthy vol. 5 1
1
Tieschky et al.160 patella axial 2.0/0.6 0.6 8 healthy vol. 6 1
(with interpolation to 0.3 0.3)
Stammberger et al.203 same sample, including thickness, and RMS 1
Eckstein et al.206 patella sag 2.0/0.3 0.3 8 healthy vol. 6 1
tot fem sag 1
med tib sag 3
lat tib sag 3
Stammberger et al.203 same sample, including thickness, and RMS CV% and SD
patella sag 1
med tib sag 3
lat tib sag 3
Cicuttini et al.67 patella sag 1.5/0.3 0.3 12 vol. (knee pain
but no OA)
2 3
tot fem sag 2
tot tib sag 5
Cicuttini et al.105 patella sag 1.5/0.3 0.6 10 healthy vol. 4 2
tot fem sag 2
tot tib sag 2
tot fem sag 8 OA pat. 2
tot tib sag (KLG  3) 3
Waterton et al.173 tot fem sag 1.6/0.5 0.5 6 healthy vol. 6 1
Jones et al.69 patella sag 1.5/0.3 0.3 10 healthy vol. 4 2
med tib sag 2
lat tib sag 2
Hardy et al.102 patella sag 1.0/0.28 0.28 4 OA pat. 2 7
0.5/0.55 0.55 (KGL 2) 5
1.0/0.55 0.55 2
2.0/0.55 05 3








CV% (SD)* mean/yRMS Upper 95% conf. limit.
(CV%)
1.0% (34 ml)y 1.2% (42 ml)
2.3% (48 ml)y 2.8% (59 ml)
2.6% (66 ml)y 3.2% (81 ml)
5.5% (56 ml)y 7.8% (80 ml)
3.8% (59 ml)y 5.4% (84 ml)
2.6% (126 ml)y 3.3% (160 ml)
2.8% (144 ml)y 3.6% (145 ml)
1.7% (383 ml)y 2.1% (467 ml)
2.0% (79 ml)y 2.4% (96 ml)
2.3% (303 ml)y 2.8% (370 ml)
3.4% (180 ml)y 4.1% (220 ml)
4.9% (211 ml)y 6.0% (257 ml)
5.3% (212 ml)y 6.5% (259 ml)
2.5% (56 ml)y 3.1% (68 ml)
2.3% (77 ml)y 2.8% (94 ml)
5.3% (114 ml)y 11% (238 ml)
2.0% (211 ml)y 4.2% (441 ml)
4.6% (107 ml)y 9.6% (224 ml)
6.7% (142 ml)y 14% (297 ml)
1.6% (57 ml)y 2.4% (87 ml)
2.2% (273 ml)* 2.9% (360 ml)
1.6% (76 ml)* 2.1% (100 ml)
2.6% (78 ml)* 3.4% (103 ml)
3.2% (26 ml)y 4.2% (34 ml)
3.0% (25 ml)y 4.0% (33 ml)
6.2% (34 ml)y 8.9% (49 ml)
4.5% (37 ml)y 6.5% (53 ml)
both condyles, FC¼ femoral condyle, fem tro¼ femoral troch-


















































Authors Surface Orient Resolution N subjects (type) Repet. (N)
Eckstein et al.196 patella axial 1.5/0.3 0.3 12 healthy vol. 4
Hyhlik-Du¨rr et al.194 med tib cor 1.2/0.3 0.3 8 healthy vol. 6
lat tib cor
Burgkart et al.118 med tib cor 1.2/0.3 0.3 8 OA pat. 2e4
lat tib cor (TKA)
Cicuttini et al.246 med FC corx 1.3/0.4 0.4 10 OA pat. 4
lat FC corx








Gandy et al.192 patella sag 1.6/0.5 0.5 5 OA pat. 2
tot fem sag (KLG¼ 2e3)
med tib sag
lat tibia sag
Sitoci et al.211 patella axial 1.5/03 0.3 12 healthy vol. 2
Raynauld et al.111 tot knee sag 1.0/0.3 0.4 8 OA pat. 2
med FT sag (KLG 2e3) 4
lat FT sag
Glaser et al.197 med FC cor 1.2/0.3 0.3 8 healthy vol. 4
lat FC cor
med FC cor 7 OA pat. 2e4
lat FC cor (TKA)
sag¼ sagittal, cor¼ coronal, tot¼ total, med¼medial, lat¼ lateral, tib¼ tibia, tot fem¼ total femur, including the trochlea and
lea, FT¼ femorotibial compartment (tibia and parts of the femoral condyle taken together), vol.¼ volunteers, pat.¼ patient, RA¼
upper conﬁdence limit.
*Mean CV% over all volunteers.
yRMS CV% over all volunteers (single coefﬁcients squared, root of mean of squares) 193.
zCV% computed not as SD of repeated measurements, but as difference of two measurements, related to their mean.
xCoronal reconstructions of images, reformatted from the sagittal to the coronal plane.
A59Osteoarthritis and Cartilage Vol. 14, Supplement Aassociated with conditions f and g. These precision
errors then need to be related to the inter-subject var-
iability of the measurements that were determined
during the study. Note that the inter-subject variability
of cartilage volume is substantially larger than that of
cartilage thickness, because of the additional inﬂu-
ence of differences in bone size. For this reason, pre-
cision errors in measuring cartilage thickness need to
be smaller than those in measuring cartilage volume
in order to achieve the same discriminatory power
(same interclass correlation coefﬁcient) in a cross-
sectional study.
(2) In a longitudinal study, image acquisitions are typically
several weeks/months apart, but image analysis can
be performed by one observer in a side-by-side fash-
ion on paired data sets within one session. Under
these conditions, one needs to take into account the
precision errors associated with condition d only.
Note, however, that under these conditions measure-
ment can only start when the ﬁrst patient returns for
follow-up examination, and this may delay availability
of ﬁnal results, particularly if the rate of recruitment
was high and the study was to be analyzed by only
one reader to minimize interobserver error. If the scan-
ner is changed or updated during the study, one must
also consider the variability associated with conditiong.
(3) If, in a longitudinal study, image analysis starts with
the baseline acquisition, one must consider the preci-
sion errors involved in conditions bþ d. These errors
could, in theory, be reduced by analyzing the follow-
up data set in direct comparison with the baseline
data set that was analyzed at an earlier point in
time. This, however, has the disadvantage of unblind-
ing the reader to the order of the examinations, which
depending on the design of the study, may bias the
results. If additionally, the reader changes over the
period of the study, one needs to know the variability
associated with condition f. Since articular cartilage
changes in OA are relatively small, whenever possi-
ble paired data sets should be analyzed by the
same reader in a single session, and the reader
should be blinded to the order of acquisition.
As stated above, most studies that examined the preci-
sion of a speciﬁc MRI acquisition protocol in conjunction
with a speciﬁc software application reported precision errors
under conditions c (inter-scan precision, short term). Table
VI lists results for cartilage volume from precision studies at
1.5 T that adhered to these conditions.
STATISTICAL CONSIDERATIONS FOR DETERMINING
PRECISION ERRORS
The way in which precision errors have most commonly
been expressed is the standard deviation (SD) or coefﬁcient
of variation (CV%; SD divided by the mean value) of re-
peated measurements (Table VI). Use of the CV% is
most appropriate when SD is proportional to volume, for in-
stance when comparing precision in different joint surfaces
of the knee (i.e., medial tibia vs total femur). If the SD is in-
dependent of volume, it is more appropriate to compare SD
values directly. In one study192 it was reported that the SD
of repeated measurements increased not linearly with carti-
lage volume but with an approximately two-thirds power
relationship. This is consistent with the hypothesis that
precision errors for cartilage volume strongly depend on
the surface area characteristics of the segmentation, sincethe surface area tends to increase also with the two-thirds
power of volume. The conﬁdence limits of the SD and
CV% reported in a precision study depend both on the num-
ber of subjects who were examined and on the number of
repeated scans from which the SD or CV% was calcu-
lated193. The conﬁdence limits cannot be determined from
the SD of the individual precision errors, but must be calcu-
lated using the asymmetric chi-square distribution, which
depends on the total number of degrees of freedom of the
study (DOF¼ number of subjects examined (number of
repeat scans 1)193. Glu¨er et al.193 recommended examin-
ing at least 14 representative subjects and to acquire at
least three to four repeated scans in each of them (28
and 42 degrees of freedom, respectively). Under these con-
ditions, the ‘‘true’’ precision error in the population is not
underestimated by more than 22% and 29%, respectively,
with 95% (one-sided) statistical conﬁdence.
Note that there are different ways to report the average
SD or CV% across several individuals in which repeated
measurements were taken. One way is to report the median
SD or CV% in the cohort. This, however, eliminates the im-
pact of large precision errors and therefore underestimates
the ‘‘true’’ precision error in the population. Reporting the
mean value of SD or CV% across subjects also underesti-
mates the precision error in the population, because the
measured variance (SD2), not the measured SD, is consid-
ered an unbiased estimate of the parameter s2 of the
Gaussian normal distribution193. For this reason, SDs or
CV%s in each subject should be squared (giving more
weight to large precision errors), and the analysis should re-
port the square root of the mean of these values in the total
sample (RMS SD or CV%)193. To permit comparison be-
tween studies, the statistical procedures involved in report-
ing precision errors are shown in Table VI, if these were
speciﬁed by the authors.
COMPARISON OF PRECISION ERRORS AMONG DIFFERENT
STUDIES, JOINT COMPARTMENTS, AND MORPHOLOGICAL
PARAMETERS
When comparing precision among studies, it is important
to take into account differences in study populations. When
examining patients with severe OA, the CV% will be larger
than that in healthy volunteers, even if the absolute error
(SD) is similar. This is because patients with severe OA
have less cartilage volume, and the error is thus divided
by a smaller denominator, resulting in a larger CV. When
examining the results in Table VI, it becomes evident that
CV%s of repeated measurements tend to be higher for
OA patients than for healthy volunteers, whereas SDs
were similar for the two groups118,194,195. CV% of cartilage
volume in the medial tibia in healthy volunteers was, with
few exceptions, reported to be in the range of 2e3.5%.
When comparing results for different joint compartments
and section orientations, the lowest precision errors (CV%
approx. 1%) were observed for axial scans of the patella196.
Relatively large precision errors, in contrast, were reported
for measurements of the femoral condyles using sagittal
scans195, whereas measurements of the total femur were
usually comparable to those of other joint surfaces of the
knee. These larger errors were attributed to partial volume
effects along the medial and lateral margins of the femoral
condyles, which are viewed en face with sagittal imaging.
No substantial difference in precision error between coro-
nal and sagittal imaging has been reported for tibial carti-
lage volume measurement in healthy volunteers. Some
authors reported, however, that in OA, coronal scans offer
A60 F. Eckstein et al.: qMRI for assessment of cartilage morphology in OAadvantages over sagittal images, because of partial volume
effects that can occur near the tibial spines on sagittal im-
ages and because of the predominantly medialelateral pat-
tern of cartilage loss in FT OA118,119,195,197. Medialelateral
cartilage loss is within the plane of section of coronal im-
ages but through the plane of section on sagittal images,
making small changes more difﬁcult to detect with the lat-
ter118,119,195,197. Smaller precision errors were recently re-
ported for measurements of the weight-bearing surfaces
of the femoral condyles using coronal scans197 than for
those of the femoral cartilage using sagittal scans195. How-
ever, apart from three studies (one in OA patients198, one in
paraplegic patients86 and one in post-traumatic patients
with partial load bearing88), most longitudinal investigationshave thus far used sagittal protocols111,192,199e201. Interest-
ingly in this context, Cicuttini and coworkers measured the
rate of progression in tibial cartilage using sagittal im-
ages199 and also using reformatted coronal images202.
They reported a higher rate of progression of tibial cartilage
loss in the reformatted coronal (around 8% per annum)202
vs original sagittal images (around 5% per annum)199.
These ﬁndings (Table VII) indicate that changes may be
more readily detected in coronal views of the knee. The ad-
vantage of sagittal scans, on the other hand, is that they of-
fer coverage of the entire knee joint, including the femoral
trochlea and the posterior convexities of the femoral con-
dyles. Which protocol (sagittal or a combination of axial
and coronal scans, which can be acquired in approximatelyTable VII
Longitudinal change of knee cartilage volume with MRI in patients without and with OA reported by different authors
Authors Subjects (duration,
months)
Surface Orient. // resol. N Loss/year (%) Loss/year (ml)
Peterfy et al.247 Normals patella sag // 2.0 / 7 0.8 2.8%
(Approx. 24) tot fem 0.6 0.6 1.8 2.7%
tot tib þ0.4 3.1%
Cicuttini et al.201 Normals tot tib sag // 1.5 / 8 þ2.3 3.0% þ61 82 ml
Meniscectomy tot tib 0.3 0.8 13 4.1 2.8% 144 104 ml
(28.6 7.6)
Wluka et al.92 Postmenopause tot tib sag // 1.5 /
(25.2 3.6) 0.3 0.8
Women with HRT 29 2.9 2.7% 100 90 ml
Women without HRT 28 2.2 2.4% 80 130 ml
Hanna et al.220 Healthy men tot tib sag // 1.5 28 2.8 1.6% 162 93 ml
(Approx. 24) 0.3 / 0.8
Peterfy et al.247 OA (KL ?) patella sag // 2.0 / 16 3.4 2.9%
Approx. 24 tot fem 0.6 0.6 6.7 5.2%
tot tib 6.3 4.3%
Wluka et al.199 OA (KL 1e3) med tib sag // 1.5 / 123 4.7 6.5% 88.4 115 ml
22.8 2.4 lat tib 0.3 0.8 5.3 7.2% 113 127 ml
Cicuttini et al.221 OA (KL 1e3) patella sag // 1.5 110 4.5 4.3% 145 154 ml
22.8 2.4 0.3 0.8 Women 5.3 4.5% 149 140 ml
Men 3.5 4.0% 140 175 ml
Diff. P< 0.03 n.s.
Wluka et al.200 OA med tib sag // 1.5 59 vitamin E 157 209 ml
24 lat tib 0.3 0.8 187 220 ml
med tib 58 placebo 186 258 ml
lat tib 251 216 ml
Gandy et al.192 OA (KL 1e3) patella sag // 1.6 11 (16) 0.9 4.5 48 144 ml
37 tot fem 0.5 0.5 0.8 2.4 104 324 ml
med tib 0.3 3.7 0 67 ml
lat tib þ1.0 2.8 þ26 53 ml
Glaser et al.198 OA med tib cor // 1.5 7 7.0 4.3% 164 95 ml
22 6 lat tib 0.31 0.31 3.5 2.3% 89 58 ml
Raynauld et al.111 OA (KL 2e3) tot knee sag // 1.0 32 3.6 5.1% 473 658 ml
24 med FT* 0.31 0.39 4.2 7.5% 261 471 ml
lat FT* 3.1 4.5% 212 301 ml
Raynauld et al.223 OA (KL 2e3) tot knee sag // 1.0 107 3.7 3.0% 376 311ml
24 med FT* 0.31 0.39 5.5 4.3% 256 211ml
lat FT* 2.1 2.9% 119 160ml
Cicuttini et al.202 OA (KL 1e3) med FC cory // 1.5 / 102 7.6 8.4% 150 330 ml
22.8 2.4 med tib 0.31 0.83 7.4 7.8% 100 250 ml
lat FC 8.7 9.7% 150 250 ml
lat tib 8.4 9.9% 130 240 ml
For abbreviations see Table VI.
*FT¼ femorotibial compartment (tibia and femoral condyle taken together).
ySagittal data reformatted to the coronal plane, as explained in Cicuttini et al.246.
A61Osteoarthritis and Cartilage Vol. 14, Supplement Athe same time) is preferable is currently a point of contro-
versy. To date, no face-to-face comparison of precision or
longitudinal change between these protocols was reported
in the same cohort of OA patients.
Note that the resolutions chosen for studies in Table VI
vary substantially. As discussed previously, only one study
has so far directly compared precision errors in the same
group of subjects for different levels of spatial resolution102.
The authors found signiﬁcantly higher precision errors for
cartilage volume measurements of the femur and tibia using
images with an in-plane resolution of 0.55 mm 0.55 mm
compared to those using images with 0.28 mm 0.28 mm
resolution. This was true despite considerably lower SNR
and CNR and longer acquisition time (22 min) of the
higher-resolution images. These observations were, how-
ever, not conﬁrmed in the patella (Table VI). Variations in
section thickness between 0.5 mm and 2.0 mm (at an in
plane resolution of 0.55 mm), on the other hand, were asso-
ciated with relatively small changes in precision error102. In
some studies, the in-plane resolution was chosen to be
asymmetrical105 in order to reduce imaging time. Interpola-
tion to an isometric in-plane resolution can offset this to
some extent; however, the effect of these approaches on
precision of quantitative cartilage measurements has not
yet been determined in a well-controlled comparative study.
Figures 4 and 5 show the results of a meta-analysis on
precision errors for cartilage volume across studies at
1.5 T shown in Table VI. Results of studies included were
weighted with the degree of freedom for each analysis193.
When including normal volunteers and patients across stud-
ies, the precision error (RMS SD) was 87 ml for patellar car-
tilage as analyzed from sagittal images, 57 ml for patellar
cartilage as analyzed from axial images, 276 ml for femoral
cartilage (total femur including the trochlea and both con-
dyles), 68 ml for the medial tibia as analyzed from sagittal
images, 50 ml for the medial tibia as analyzed from coronal
images, 92 ml for the lateral tibia tibia as analyzed from sag-
ittal images, and 64 ml for the lateral tibia as analyzed from
coronal images. When combining data from studies using
a sagittal and coronal protocol in the tibia, values (RMS
SD) were 61 ml in the medial and 81 ml in the lateral tibia.
Precision errors of computations of the mean cartilage
thickness throughout joint surfaces118,194,195,203 and for
quantiﬁcations of joint surface area153,195,204 were reported
to be similar to those of cartilage volume. These steps in the
analysis thus do not involve a loss in precision over the nu-
merical integration of segmented voxels, but may substan-
tially deepen information on speciﬁc structure related
disease processes in OA.
COMPARISON OF PRECISION ERRORS FOR DIFFERENT FIELD
STRENGTHS AND SEGMENTATION INPUT DEVICES
Using a dedicated, peripheral 1.0 T scanner123, precision
errors for cartilage volume and thickness in the FT joint from
coronal images were found to range from 2.9% to 5.6%
(RMS average CV% for conditions c (see above)) in six
healthy participants and six OA patients. In the same partic-
ipants, precision errors were 1.6e3.4% for scans obtained
with a whole-body 1.5 T scanner. This suggests that the
precision for quantitative cartilage measurements on dedi-
cated peripheral systems still falls somewhat short of those
obtained with 1.5 T whole-body magnets, but may still be
within acceptable limits for clinical trials.
Recently, precision errors were directly compared be-
tween a 1.5 T and 3.0 T whole-body scanner in 15 healthy
subjects and 15 OA patients129. For 1.5 mm partitionthickness at 1.5 T, the average precision errors in the FT
joint (coronal scans) were 3.0% and 2.6% for cartilage vol-
ume and thickness, respectively. The errors were smaller
for 1.5 mm at 3.0 T (2.6% and 2.5%) and still smaller for
1.0 mm at 3.0 T (2.1% and 2.0%). It was concluded that
3.0 T cartilage imaging yielded somewhat smaller precision
errors than 1.5 T and the reduction in partition thickness
was more effective than a gain in S/CNR.
In context of an OA initiative pilot study, a recent paper
compared the ‘‘overall precision errors’’ (conditions e) at


































































Fig. 4. Graph showing meta-analysis for precision (RMS CV%) of
cartilage volume measurements for various section orientations in
different compartments of the knees of healthy volunteers. Results
from the studies were weighed with the degrees of freedom
(DOF)193 of the precision analysis. Studies including patients
were not included in this part of the analysis, because only the
CV% but not the SD of repeated measurements can be compared
directly between different cartilage plates of the knee. The CV%,
however, is higher in patients with OA, because the SD of repeated
measurements is divided by a smaller denominator (mean volume).
Therefore, the CV% of precision analyses in OA patients depends
on the degree of cartilage loss and is problematic to compare be-
tween studies, when patients with different stages of disease are in-
cluded. Studies that reported the CV% for either the total tibia
(medial and lateral) or the tibia and contacting femur together
(i.e., medial tibia and medial femoral condyle) were not included
in the meta-analysis, because the values could not be attributed
to an individual cartilage plate. Results are also not summarized
for studies in the femoral condyles, because studies analyzed
highly variable regions of interest of the femur: (1) patella sagittal,
total number of DOF¼ 154, studies included Refs.67,69,105,195,203;
(2) patella axial, total number of DOF ¼ 88, studies included
Refs.196,203 ,211; (3) total femur sagittal , total number of
DOF ¼ 154, studies included Refs.67,105,173,195,206; (4) medial
tibia sagittal, total number of DOF ¼ 112, studies included
Refs.69,195,203. Studies 31 and 58 were not included, because
they report precision in the total tibia. Study 62 was not included,
because precision was reported for the tibia and femoral condyle
taken together. (5) Medial t ibia coronal, total number of
DOF¼ 40, study included Ref.194; (6) lateral tibia sagittal, total
number of DOF¼ 112, studies included Ref.69,195,203. Studies 31
and 58 were not included, because they report precision in the total
tibia. Study 62 was not included, because precision was reported
for the tibia and femoral condyle taken together; (7) lateral tibia cor-
onal, total number of DOF¼ 40, study included Ref.194.
A62 F. Eckstein et al.: qMRI for assessment of cartilage morphology in OAbetween a coronal FLASH water-excitation sequence
(1.5 mm section thickness), a sagittal DESS we sequence
(0.7 mm section thickness) and coronal multiplanar recon-
structions from the DESS we sequence (at 1.5 mm section
thickness)130. In the FT joint, precision errors for cartilage
volume and thickness were 3.1e6.4% for the coronal
FLASHwe, 2.3e8.2% for the sagittal DESSwe, and
2.5e6.2% for coronally reconstructed DESSwe130. In the
PF joint (patella and trochlea), precision errors of the sagit-
tal DESSwe were 3.4e8.5%, which is higher than observed
in previous studies with FLASHwe at 1.5 T with 1.5 mm sec-
tion thickness under resegmentation conditions (see be-
low). The authors commented that sagittal DESSwe may
thus be less suitable for analyzing the PF joint compared

































































Fig. 5. Graph showing meta-analysis for precision (RMS SD) of car-
tilage volume measurements for various section orientations in dif-
ferent compartments of the knees of healthy volunteers. Results
from different studies were weighed with the degrees of freedom
(DOF)193 of the precision analysis. In this part of the analysis, stud-
ies including patients were included. Studies that reported the SD
for either the total tibia (medial and lateral) or the tibia and contact-
ing femur together (i.e., medial tibia and medial femoral condyle)
were also not included in the meta-analysis, because they could
not be attributed to an individual cartilage plate. Results are also
not summarized for studies in the femoral condyles, because these
analyzed variable regions of interest of the femur. List of studies in-
cluded: (1) patella sagittal, total number of DOF¼ 149, studies in-
cluded Refs.67,105,113,192,195,203; (2) patella axial, total number
of DOF ¼ 88, studies included Refs.196,203,211; (3) total femur
sag i t ta l , to ta l number o f DOF ¼ 162, s tud ies inc luded
Refs.67,105,113,173,192,195,206; (4) medial tibia sagittal, total number
of DOF¼ 87, studies included Refs.192,195,203. Studies 31 and 58
were not included, because they report precision in the total tibia.
Study 62 was not included, because precision was reported for
the tibia and femoral condyle taken together. (5) Medial tibia coro-
nal, total number of DOF¼ 56, study included Refs.118,194; (6) lat-
eral tibia sagittal, total number of DOF ¼ 87, studies included
Refs.192,195,203. Studies 31 and 58 were not included, because
they report precision in the total tibia. Study 62 was not included,
because precision was reported for the tibia and femoral condyle
taken together. (7) Lateral t ibia coronal, total number of
DOF¼ 56, study included Refs.118,194. A combined analysis of
data at the medial tibia (sagittal and coronal) revealed an average
precision error of 61 ml, and a combined analysis at the lateral tibia
of 81 ml.of the performance of the two sequences in the PF joint
was carried out in this study130.
McWalter et al.205 studied the effect of various interactive
computer input devices (interactive digitizing tablet, interac-
tive touch-sensitive screen, traditional mouse) on cartilage
segmentation by evaluating segmentation time, consis-
tency, and precision. Medial tibial and patellar cartilage of
six healthy and six OA knees were segmented twice (1
week apart) using the three devices. It was found that for
a new user, segmenting with an interactive touch-sensitive
screen reduced segmentation time by about 15% when
compared to the traditional mouse, but no signiﬁcant differ-
ence was observed in segmentation time between the inter-
active digitizing tablet and the mouse. Also there was no
systematic offset between the input devices or the precision
error under resegmentation conditions, so that the devices
may be used interchangeably according to personal
preference.
INTER-OBSERVER, LONG-TERM, AND RESEGMENTATION
PRECISION
Several studies examined the inter-observer and intra-ob-
server (inter-scan) precision of repeated analy-
ses104,105,113,114,159,169,206. These studies usually reported
considerably larger precision errors when different ob-
servers were involved in the segmentation than when a sin-
gle reader was used. Although the inter-observer error can
be effectively reduced by using semi-automated segmenta-
tion methods159 or by using rule-based protocols169, it is
preferable that cross-sectional data and essential that
paired data from longitudinal studies be analyzed by the
same user.
When precision errors were systematically compared in
healthy volunteers under short-term imaging conditions (ac-
quisitions immediately after each other with joint reposition-
ing), long-term imaging conditions (acquisitions taken
roughly over 9 months, but measurement of images within
one session), and resegmentation of the same data sets
spaced over 12 months195, it was found that these were
not signiﬁcantly larger under long-term than under short-
term acquisition conditions. Also, no systematic drift was
observed in the data, suggesting that scanner conditions
had remained stable throughout the study period. To avoid
differences in subject conditions (due to differences in
levels of physical activity prior to imaging e cartilage com-
pression), volunteers were asked to rest for 1 h prior to
the image acquisition. This was because other studies
had shown that knee bends and squatting can cause a re-
duction of approx. 5% in patellar cartilage volume and thick-
ness196,207 and this effect was shown to last for approx.
90 min208. When volunteers rested for 45 min prior to imag-
ing (following normal activity), no systematic increase was
observed during repeated measurements in a supine posi-
tion160,206. This suggests that resting subjects for a period
of 45e60 min is sufﬁcient to exclude changes associated
with physical activity. As femoral cartilage is known to be
stiffer than patellar cartilage209, these effects are likely
less in the FT joint and this was recently conﬁrmed when
studying FT cartilage deformation after different types of
loading210. Waterton et al.173 reported no diurnal effects
(evening vs morning acquisition) on femoral cartilage vol-
ume, but reported a decrease in cartilage thickness in the
femoral contact areas. When examining volunteers over-
night (8 h), after a day of normal activity, Sitoci et al.211
found only a 1.6% increase of patellar cartilage thickness.
It should also be kept in mind, however, that cartilage
A63Osteoarthritis and Cartilage Vol. 14, Supplement Amay soften in OA, and that activity induced compression of
the cartilage may thus be a relevant source of variability in
clinical studies.
Resegmentation of the same data sets over a period of 1
year by the same user involved larger errors than those in-
volved by segmentation of different data sets immediately af-
ter each other (sagittal FLASHwe at 1.5 T and 1.5 mm
section thickness)195 and the differences in precision did at-
tain statistical signiﬁcance for some surfaces. Nevertheless,
resegmentation errors were substantially lower than the in-
ter-subject variability in cartilage volume, thickness, and sur-
face areas of healthy volunteers, so that cross-sectional
studies are not critically affected195. For an axial imaging pro-
tocol of patellar cartilage (FLASHwe at 1.5 T, 1.5 mm section
thickness), the overall precision error (image acquisition and
segmentation spread over a period of 12 months) was 1.6%
for cartilage volume, in comparison with 1.0% for short term
imaging and short term segmentation conditions210. Reseg-
mentation errors critically depend on the experience and tal-
ent of the user and are thus difﬁcult to generalize. However,
results of the above studies favor the approach of paired
analysis of baseline and follow-up data sets in longitudinal
studies. Blinding the user to the order of the exams may be
necessary in such an approach in order to avoid bias.
Sensitivity to change of quantitative
cartilage measurements
CROSS-SECTIONAL STUDIES ON CARTILAGE
CHANGES WITH MRI
Estimates of cartilage thinning during normal aging (in the
absence of OA) were derived from cross-sectional data ob-
tained in elderly healthy subjects without history of knee
joint symptoms, trauma, or surgery (50e78 years; 11
men, 12 women) relative to a cohort of young, healthy
subjects who met the same criteria (20e30 years; 49
men, 46 women). The authors73,74 reported an estimated
0.3e0.5% reduction of cartilage thickness per annum for
all knee compartments. In the patella, women displayed
a higher loss than men, but no gender difference was found
for other compartments of the knee73,74.
Burgkart et al.118 determined cartilage volume in eight OA
patients prior to TKA and estimated the loss by comparison
with a group of 28 healthy subjects79. They reported a differ-
ence of approx. 1300 ml in the medial tibia in patients with
varus OA, and differences of approx. 1800 ml in the lateral
tibia in patients with valgus or bicompartmental OA. These
values were found to exceed the precision error in the tibia
of healthy volunteers and OA patients (approx. 60 ml) by
a factor of >20:1, but T-scores (deviation from data in
young, healthy volunteers expressed as difference divided
by SD of data in volunteers) were only moderate. Recently,
larger age- and gender-speciﬁc reference data on normal
volunteers were published63,73,74,212 for providing T- and
Z-scores in OA204, as they are currently used in the diagno-
sis of osteoporosis213. One problem with this approach is
the relatively large inter-subject variability of cartilage vol-
umes in healthy subjects63,73,74,79,212. Because only a
weak correlation between cartilage volume and body height
and weight63,67,69,73,79 exist, but a much larger one with
bone size74,78,79 it has been suggested that cartilage volume
should be normalized to the original premorbid bone inter-
face area (before the onset of OA) of respective cartilage
plates, in order to achieve better discrimination between
OA patients and healthy subjects63,74,79,204. By comparing
patients prior to osteotomy and TKA with young healthyand age-matched normal volunteers it was shown that nor-
malization to original bone interface area is more effective
than normalization to body weight and height and can mark-
edly enhance the T-scores for OA patients204. This was
supported by results from a larger population-based study
(Framingham cohort), in which the best discrimination
between patients with ROA of the FT joint and non-ROA
participants was found for cartilage volume divided by the
bone interface area214.
One recent study215 looked at the correlation of cartilage
morphology in the normal ankle and knee, in a conceptional
attempt to retrospectively estimate cartilage loss more ac-
curately in a diseased knee, by extrapolating premorbid
knee cartilage morphology from measurements in an
healthy ankle in the same subject. However, the correla-
tions were shown to be only moderate (r¼ 0.33e0.81 for
cartilage volume and 0.0e0.51 for thickness).
Cicuttini et al.212 examined the relationship between tibial
cartilage volume and radiographic grade of OA (osteo-
phytes and semi-quantitative grade of JSN) in 252 subjects
with different stages of OA. They reported that the inverse
relationship between the grade of JSN and cartilage volume
was linear, stronger than that between osteophytes and car-
tilage volume, and strengthened when values were ad-
justed for age, gender, BMI, and bone size. For every
grade in JSN (0e3) there was, on average, a 257 ml (95%
conﬁdence interval [CI], 195e321 ml) reduction of the me-
dial tibial cartilage and a 396 ml (95% CI: 283e509 ml)
reduction of the lateral tibia. Based on subgroups with no
sign of ROA (36 men and 65 women), they proposed
a model to estimate average ‘normal’ cartilage volume in
men and women for a given age, BMI, and bone size. Jones
et al.216 conﬁrmed these ﬁndings for the lateral tibia and
patella as well in another sample of 372 subjects (adjusted
mean difference¼11e13% for grade 1 JSN, but no asso-
ciation of cartilage volume change with osteophytes), and
they additionally reported the bone interface area to be sig-
niﬁcantly larger in grade 1 JSN (adjusted mean differ-
ence¼þ10e16%). This in turn was shown to be the case
for another cohort of 149 women with OA examined by
Wluka et al.217, in which tibial plateau size area was posi-
tively associated with both osteophytes and JSN. In the
PF joint, there was also a signiﬁcant inverse relationship be-
tween patellar cartilage volume and JSN on lateral and sky-
line PF radiographs218, with the association for skyline
radiographs (r¼0.54, P< 0.001) being stronger than for
lateral radiographs (r¼0.16, P¼ 0.015). No association
was found between patellar cartilage volume and osteo-
phytes in PF radiographs218.
Optimization of cross-sectional analysis is particularly im-
portant for patient selection into longitudinal trials. It has
been shown that patients with >2 mm JSW in semiﬂexed
weight-bearing radiographs of the medial FT compartment
display a higher rate of progression of OA than those with
a JSW of <2 mm219. Patients with certain features of carti-
lage morphology may therefore be more suitable candi-
dates for trials on treatment effects in OA than others.
Low cartilage volume is not a suitable selection criterion,
because this would bias toward subjects with small bone
size rather than subjects with reduced cartilage thickness,
since it has been shown that cartilage thickness and joint
size are not highly correlated79. The ratio of ‘‘cartilage vol-
ume over original bone interface area’’ (before the onset
of disease) or the ‘‘percentage of cartilaginous (denuded)
joint surface area’’, however, may prove to be useful param-
eters in patient selection. This, however, remains to be in-
vestigated in longitudinal trials.
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Data on changes in cartilage volume from longitudinal
studies are summarized in Table VII. No signiﬁcant
changes in cartilage volume were observed in 166 healthy
volunteers aged 21e79 years over a period of approx. 2
years201, but signiﬁcant cartilage loss (4.1% per annum)
was detected in a group of patients who had undergone
partial meniscectomy201 (Table VII).
Wluka et al.92 reported a signiﬁcant change in cartilage
volume in postmenopausal women, with signiﬁcant differ-
ences in participants with and without hormone replace
therapy (HRT). In healthy middle-aged men (aged 52 13
years), Hanna et al.220 found a signiﬁcant (2.8% annual)
reduction in total tibial cartilage volume over a 2 year period,
which was signiﬁcantly associated with free serum testos-
terone levels (partial r2¼ 14.5%). The correlation between
cartilage loss and urinary N-telopeptide cross-links of type
I collage (Ntx) reached borderline signiﬁcance (P¼ 0.057).
Figures 6 and 7 display the result of a meta-analysis of
the annual rate of change in these compartments, with
data being summarized from studies on OA patients in Ta-
ble VII. For this analysis, the rate of change was weighted
with the number of subjects in each study. The combined
annual loss of cartilage volume reported in these studies
was 136 ml (4.1%) in the patella, 90 ml (5.6%) in the
medial tibia, and 107 ml (6.0%) in the lateral tibia. How-
ever, results varied between studies, the annual rate of
change ranging from 0.3%192 to 7.4%202 in the medial
tibia (Fig. 8).
Wluka et al.199 examined the medial and lateral tibia of
123 patients (52 men, 71 women; age 63.1 10.6 years)
with symptoms (WOMAC score¼ 427 225) and with ra-
diographic evidence of OA (8% with a Kellgren Lawrence
grade (KLG) 1, 46% with KLG 2, and 46% with KLG 3)
over a period of almost 2 years. They found no signiﬁcant
difference in the amount of relative (%) cartilage loss be-
tween women and men, and only a relative low (albeit sta-
tistically signiﬁcant) correlation between changes in the
medial and lateral tibia (r¼ 0.25, P< 0.01). Subjects with
a larger cartilage volume at baseline displayed a trend to-
ward higher absolute and relative (%) cartilage loss during
the study. Cicuttini et al.221 analyzed patellar cartilage
changes in 110 patients from the same cohort. The rate
of relative (%) cartilage loss was signiﬁcantly higher in
women compared with men (P< 0.03; Table VII), and there
was no signiﬁcant association between change in the pa-
tella and both the medial (r¼ 0.08, P¼ 0.43) and lateral
(r¼ 0.02, P¼ 0.86) tibia. Subjects with higher baseline
pain scores displayed higher loss than those with lower
pain scores, and so did those with higher BMI. Femoral car-
tilage change measured using coronal images reformatted
from sagittal images of a subgroup of 117 subjects202 dis-
played a similar rate of progression as those in the tibia
when analyzed from the same (reformatted) data sets
(around 8% per annum), but a higher rate than reported pre-
viously in the tibia when the analysis was based on sagittal
image data. A relatively high association was observed be-
tween the relative loss in the medial femoral condyle and
medial tibia (r¼ 0.81, P< 0.001), and between the lateral
femoral condyle and lateral tibia (r¼ 0.71, P< 0.001)202.
In the same sample, the medial and lateral tibial plateau
area was shown to increase over a 2 year period (2.2% and
1.5% per annum, respectively), with increases at the medial
(but not lateral) tibia being stronger in males, in participants
with high BMI, and in subjects with higher baseline grade of
medial JSN222. There are currently no data on the relativecontribution of changes in cartilage thickness and reduction
of cartilaginous joint surface area (increase in denuded joint
surface area) in OA, but it is expected that these data will be
available soon.
CORRELATION OF LONGITUDINAL CARTILAGE CHANGES
IN MRI WITH RADIOGRAPHY
Only few studies have directly compared change of carti-
lage volume from MR images to quantitative measurements
of JSN in radiographs, and these have produced contradic-
tory results: the study by Gandy et al.192 (11 OA patients ex-
amined over a 3 year period) reported an expected rate of
change in the medial FT compartment of weight-bearing ex-
tended radiographs (0.21 mm), but found no signiﬁcant
change of MRI cartilage volume in any of the knee compart-
ments (Table VII). The authors argued that radiography
may be more sensitive than measurements of total cartilage
plates by MRI, because radiographic measurements are
obtained in the central aspect of the joint surface, where
most of the change typically occurs. However, it should
also be kept in mind that the cohort was relatively small
(11 patients) and that e in contrast to most other studies
e the authors used a 1.0 T (rather than 1.5 T) magnet,
and reported relatively high precision errors192. In contrast,


























N = 137 N = 27 N = 130 N = 130
Fig. 6. Graph showing meta-analysis for longitudinal change (%) of
cartilage volume measurements in different compartments of the
knee. Results from different studies were weighed with the number
of subjects within each trial. Studies that reported change for the to-
tal tibia (medial and lateral)247 or the tibia and contacting femur
together111,223 were not included in the meta-analysis, because
they could not be attributed to an individual cartilage plate. List of
studies included: (1) patella, number of subjects¼ 137, studies in-
cluded Refs.192,221,247; (2) total femur, number of subjects¼ 27,
studies included Refs.192,247; (3) medial tibia, number of sub-
jects¼ 130, studies included Refs.192,198,199,202. Please note that
results from the studies of Refs.199,202 were averaged as they
were analyzed from two different scan orientations (sagittal and re-
formatted coronal) from the same cohort. The number of partici-
pants (N¼ 123 and 102, respectively) was averaged to N¼ 112.
Study 62 was not included, because volume loss was reported
for the tibia and femoral condyle taken together. (4) Lateral tibia,
number of subjects¼ 130, studies included Refs.192,198,199,202.
Please note that results from the studies of Refs.199,202 were aver-
aged as they were analyzed from two different views (sagittal and
reformatted coronal) from the same cohort. Again, study 62 was
not included, because volume loss was reported for the tibia and
femoral condyle taken together.
A65Osteoarthritis and Cartilage Vol. 14, Supplement Amedial FT compartment of weight-bearing semiﬂexed radio-
graphs positioned with ﬂuoroscopy (reduction in JSW only
0.05 mm) in 32 patients with OA over 2 years, but re-
ported a highly signiﬁcant change of cartilage volume
from MRI both in the medial and lateral FT compartment
(volumes of femur and tibia analyzed together e Table
VII). The results were recently conﬁrmed in a larger sample
by the same group223. Cicuttini et al.224 compared the rate
of change of tibial and femoral cartilage volume with JSN in
fully extended weight-bearing radiographs in 28 subjects,
for which appropriate alignment was ensured at both base-
line and follow-up. Although there was a moderate and sta-
tistically signiﬁcant association of JSW with tibial and
femoral cartilage volume in the medial FT compartment at
baseline (r¼ 0.58e0.66, P< 0.001), there was no signiﬁ-
cant correlation between JSN and longitudinal change of
cartilage volume over 2 years (r< 0.13)224.
In the PF joint, Ciciuttini et al.225 found changes in the
narrowest joint space on lateral PF radiographs (but not
changes at the mid-patella joint space, or loss of joint space
in the medial or lateral patellar facet in skyline radiographs)
to be correlated with change in patellar cartilage volume of
4.4% over 2 years (r¼ 0.22, P¼ 0.03). Whereas for patellar
cartilage volume the SD of the change (143 ml) was similar
to the magnitude of change (133 ml), this ratio varied
between 4:1 and 19:1 for the various radiographic mea-
sures225, indicating better diagnostic performance of MRI-
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Fig. 7. Graph showing meta-analysis for longitudinal change (abso-
lute change) of cartilage volume measurements in different com-
partments of the knee. Results from different studies were
weighed with the number of subjects within each trial. Studies
that reported the precision for the total tibia (medial and lateral) or
the tibia and contacting femur together were also not included in
the meta-analysis, because they could not be attributed to an indi-
vidual cartilage plate. List of studies included: (1) Patella, number of
subjects¼ 121, studies included Refs.192,221; (2) total femur, data
not given, because only one study Ref.192 reported absolute loss
in the total femur; (3) medial tibia, number of subjects¼ 130, stud-
ies included Refs.192,198,199,202. Please note that results from the
studies of Refs.199,202 were averaged as they were analyzed from
two different views (sagittal and reformatted coronal) from the
same cohort. The number of participants (N¼ 123 and 102, respec-
tively) was averaged as well to N¼ 112. (4) Lateral tibia, number of
subjects¼ 130, studies included Refs.192,198,199,202. Please note
that results from the studies of Refs.199,202 were averaged as
they were analyzed from two different views (sagittal and reformat-
ted coronal) from the same cohort.FACTORS ASSOCIATED WITH THE MAGNITUDE OF CHANGES
OF CARTILAGE MORPHOLOGY
In order to be able to efﬁciently select patients for
DMOAD trials, it is of high interest to elucidate the factors
that predict longitudinal cartilage loss in patients, in order
to be able to observe drug effects at narrower time
scales226.
In 86 healthy middle-aged subjects (54 9 years) without
symptoms and radiographic signs of OA, Cicuttini et al.82 re-
ported a loss of muscle mass to be signiﬁcantly associated
with medial and lateral tibial cartilage volume change, but
no association between fat mass and the rate of tibial carti-
lage change. Of these asymptomatic subjects, 61% had
medial non-full-thickness cartilage lesions, and 43% had
lateral lesions227. Those with lesions displayed between
15% and 25% lower cartilage volumes at baseline and
lost cartilage more rapidly (2.5% annually in the medial
tibia) compared with those without lesions (1.3% annu-
ally)227. These ﬁndings suggest that the presence of
asymptomatic, non-full-thickness medial cartilage defects
identiﬁes ‘‘healthy’’ subjects most likely to lose knee carti-
lage in the absence of ROA.
In 117 patients with symptomatic knee OA, Cicuttini
et al.228 reported a signiﬁcant correlation between cartilage
volume at baseline and the knee angle. Longitudinally, for
every 1( increase in baseline varus angulation there was
an average loss of 17.7 ml of medial femoral cartilage, and
a weaker (non-signiﬁcant) association for the medial tibia.
Another cross-sectional study with patients prior to knee ar-
throplasty, in contrast, found the association between knee
angle and cartilage volume (normalized to bone interface
area) to be stronger for the tibia than for the femur, this ﬁnd-
ing applying to both the medial and lateral FT
compartment229.
Raynauld et al.111 reported that the subjects who lost car-
tilage more rapidly had a higher BMI, reduced range of joint
motion, and a larger knee circumference at baseline. In the
same sample111, Berthiaume et al.230 reported that 75% of
the 32 patients with ‘‘primary’’ symptomatic OA had menis-































































Fig. 8. Graph showing change of cartilage volume (%) across var-
ious longitudinal studies in the medial femoro-tibial compartment of
OA patients111,192,198,199,202.
A66 F. Eckstein et al.: qMRI for assessment of cartilage morphology in OAassociated with progression (loss in cartilage volume). Sub-
jects with medial meniscal tear had a >2-fold higher rate of
change in the medial FT compartment than those without
and those with meniscal extrusion a >3-fold higher rate
than those without.
Trabecular bone changes were found to be associated
with cartilage volume in a cross-sectional study involving
healthy subjects and OA patients, with loss of structure be-
ing most prominent in the opposite FT compartment231. An
association of trabecular bone changes was also observed
longitudinally with cartilage volume loss22, but the relation-
ship was inverse for trabecular bone changes close to,
and far from, the knee joint cavity.
In a cross-sectional sample of 372 male and female sub-
jects, the prevalence of cartilage defects (score of 2) was
shown to be signiﬁcantly associated with medial tibiofe-
moral osteophytes and tibial plateau area. Knee cartilage
defects were signiﬁcantly associated with medial tibial car-
tilage volume, but not with JSW after adjustment for osteo-
phytes143. In a longitudinal study in 117 patients with
symptomatic knee OA, in contrast, only patellar cartilage
defects (at baseline) were signiﬁcantly associated with
higher patellar cartilage volume loss over 2 years, but not
medial tibial cartilage defects with medial tibial cartilage vol-
ume loss or lateral tibia cartilage defects with lateral tibia
cartilage volume loss149.
In a sibpair study of 115 subjects followed over 2.4 years,
Zhai et al.148 reported the adjusted heretibility estimates of
cartilage volume change to be 73% for the medial and 40%
for the lateral FT compartment, and suggested that early
longitudinal changes in knee structures with relevance to
later OA display a strong genetic component.
CORRELATION OF CHANGES IN CARTILAGE MORPHOLOGY
WITH CLINICAL SYMPTOMS AND CLINICAL OUTCOME
As mentioned previously, one study showed that in pa-
tients with OA only the degree of cartilage pathology seen
in MR images is associated with clinical symptoms,
whereas other image features determined from MR images
or conventional radiographs are not33. Phan et al.232 found
the longitudinal cartilage loss (increase in cartilage lesions),
however, not to be associated with a change in symptoms,
as determined by the WOMAC score, in a group of 42
subjects.
In a cross-sectional study, Hunter et al.233 observed a sig-
niﬁcant negative association of patellar cartilage volume (as
determined from T2-weighted, fat saturated sagittal gradient
echo MR images) with the WOMAC score in an unselected
community based population of 133 postmenopausal
women. Wluka et al.234 reported a weak association be-
tween tibial cartilage volume and symptoms (WOMAC) at
baseline in a sample for 132 patients with symptomatic
early knee OA, but no signiﬁcant associations with symp-
toms at baseline and subsequent cartilage loss. However,
worsening of symptoms over a 2 year period was weekly
associated (r¼ 0.17e0.28, P¼ 0.07e0.002) with tibial carti-
lage loss234. Raynauld et al.111, in contrast, found subjects
with more pain at baseline to progress faster, but observed
no signiﬁcant correlation between change in cartilage vol-
ume and worsening of symptoms.
In the study of Ciciuttini et al. previously described202,221,
113 patients were followed until year 4 after baseline, and
the rate of cartilage loss between baseline and follow-up
at year 2 was found to be signiﬁcantly associated with
knee replacement at 4 years after baseline235. For every
1% increase in the rate of tibial cartilage loss there wasa 20% increased risk of undergoing TKA at 4 years. Partic-
ipants with the highest tertile of tibial cartilage loss had a 7.1
higher odds of TKA than those in the lowest tertile235. In
contrast, radiographic scores of OA were no signiﬁcant pre-
dictors of TKA. When being compared with quantitative
measurements of JSN in a subset of 28 patients224, longitu-
dinal cartilage volume change in the medial FT compart-
ment displayed borderline signiﬁcance in predicting TKA
at year 4 (P¼ 0.07), but JSN did not (P¼ 0.92). These
data suggest that treatment targeted at reducing the rate
of knee cartilage loss in subjects with symptomatic OA
may be strongly related to clinical outcomes and may delay
knee replacement. This is an important indication that pro-
tecting the morphological integrity and structure modiﬁca-
tion of articular cartilage in OA has merit in the treatment
of the disease, and that MRI may be superior to radiography
in monitoring relevant structural changes of joints in OA.
Conclusions
MRI is a 3D technique that displays unparalleled ability to
evaluate articular cartilage. Quantitative MRI (qMRI) has al-
ready brought about dramatic advances in the understand-
ing of normal cartilage morphology and its physiological
determinants in healthy individuals. It is certain that more
data will be available over the coming years from larger stud-
ies such as the OA initiative, and, population-based epide-
miological trials, which will have an impact on our view of
risk factors and pathophysiology of OA, and our ability to
prevent and combat the disease with better therapy.
Semi-quantitative scores and fully quantitative methods
have been developed for assessment of cartilage status
in joint disease. Semi-quantitative scores have been shown
to display high intra- and inter-reader reliability as well as
adequate speciﬁcity and sensitivity in relation to arthros-
copy, and to detect progression of cartilage damage at rea-
sonable observation periods of 1e2 years. Quantitative
assessment of cartilage from high-resolution MRI with fat-
suppressed gradient echo sequences and speciﬁc, digital
image analysis techniques have permitted access to a series
of very valuable morphological parameters that permit diag-
nosis of disease state and monitoring of its progression.
qMRI displays a high degree of accuracy (technical validity)
in relation to a variety of methods, and to display a sufﬁcient
degree of precision (reproducibility) for cross-sectional and
longitudinal studies in OA patients. There is currently some
controversy (1) over the spatial resolution (section thick-
ness, in-plane resolution) that is required (with given trade
offs in acquisition time) to resolve cartilage changes in
knee OA, and (2) over the most suitable section orientation
(sagittal, coronal) for imaging the FT joint in OA patients.
Several recent longitudinal studies have shown that
changes in cartilage volume of the order of 4% to 6%
per annum occur in most knee compartments in OA.
qMRI now is at a state where it can be introduced to large
scale epidemiological studies into OA progression, and
into clinical trials on treatment response to potential
D/SMOADs. The potential advantages of qMRI vs other
techniques are that it permits direct, reliable assessment
of articular cartilage and that it provides reliable data
throughout all knee compartments. Image acquisition (pa-
tient positioning) is less critical and thus more robust in
multi-center trials. Moreover, recent ﬁndings indicate that
longitudinal changes of cartilage morphology measured
with qMRI are more tightly correlated with clinical outcome
(symptoms, time to knee arthroplasty) than measurement
A67Osteoarthritis and Cartilage Vol. 14, Supplement Aof JSN from radiographs. Further developments in MR se-
quence technology and image analysis tools will likely
lead to further advances in evaluating disease status and
monitoring progression. These properties will render qMRI
an invaluable tool for both epidemiological studies and clin-
ical trials of treatment response to D/SMOADs.
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